<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Exp Med</journal-id><journal-id journal-id-type="hwp">jem</journal-id><journal-title-group><journal-title>The Journal of Experimental Medicine</journal-title></journal-title-group><issn pub-type="ppub">0022-1007</issn><issn pub-type="epub">1540-9538</issn><publisher><publisher-name>The Rockefeller University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19414557</article-id><article-id pub-id-type="publisher-id">20082311</article-id><article-id pub-id-type="doi">10.1084/jem.20082311</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Ikaros controls isotype selection during immunoglobulin class switch recombination</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sellars</surname><given-names>MacLean</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff1">3</xref><xref ref-type="aff" rid="aff2">4</xref><xref ref-type="aff" rid="aff3">5</xref><xref ref-type="aff" rid="aff4">6</xref></contrib><contrib contrib-type="author"><name><surname>Reina-San-Martin</surname><given-names>Bernardo</given-names></name><xref ref-type="aff" rid="aff1">2</xref><xref ref-type="aff" rid="aff1">3</xref><xref ref-type="aff" rid="aff2">4</xref><xref ref-type="aff" rid="aff3">5</xref><xref ref-type="aff" rid="aff4">6</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Kastner</surname><given-names>Philippe</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff1">3</xref><xref ref-type="aff" rid="aff2">4</xref><xref ref-type="aff" rid="aff3">5</xref><xref ref-type="aff" rid="aff4">6</xref></contrib><contrib contrib-type="author"><name><surname>Chan</surname><given-names>Susan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff1">3</xref><xref ref-type="aff" rid="aff2">4</xref><xref ref-type="aff" rid="aff3">5</xref><xref ref-type="aff" rid="aff4">6</xref></contrib><aff id="aff1"><label>1</label><institution>Laboratory of Hematopoiesis and Leukemogenesis</institution>, <label>2</label><institution>Laboratory of the Molecular Biology of B Cells</institution>, and <label>3</label><institution>Department of Cancer Biology, Institut de G&#x000e9;n&#x000e9;tique et de Biologie Mol&#x000e9;culaire et Cellulaire, 67400 Illkirch, France</institution></aff><aff id="aff2"><label>4</label><institution>Institut National de la Sant&#x000e9; et de la Recherche M&#x000e9;dicale U964, 67400 Illkirch, France</institution></aff><aff id="aff3"><label>5</label><institution>Centre National de la Recherche Scientifique UMR7104, 67400 Illkirch, France</institution></aff><aff id="aff4"><label>6</label><institution>Universit&#x000e9; de Strasbourg, 67000 Strasbourg, France</institution></aff></contrib-group><author-notes><corresp>CORRESPONDENCE Susan Chan: <email>scpk@igbmc.fr</email> OR Philippe Kastner: <email>scpk@igbmc.fr</email></corresp><fn><p>M. Sellars&#x02019;s present address is Molecular Pathogenesis Program, The Helen L. and Martin S. Kimmel Center for Biology and Medicine at the Skirball Institute for Biomolecular Medicine, New York University School of Medicine, New York, NY 10016.</p></fn></author-notes><pub-date pub-type="ppub"><day>11</day><month>5</month><year>2009</year></pub-date><volume>206</volume><issue>5</issue><fpage>1073</fpage><lpage>1087</lpage><history><date date-type="received"><day>15</day><month>10</month><year>2008</year></date><date date-type="accepted"><day>6</day><month>4</month><year>2009</year></date></history><permissions><copyright-statement>&#x000a9; 2009 Sellars et al.</copyright-statement><copyright-year>2009</copyright-year><license license-type="openaccess" xlink:href="http://creativecommons.org/licenses/by/2.0/"><license-p>This article is distributed under the terms of an Attribution&#x02013;Noncommercial&#x02013;Share Alike&#x02013;No Mirror Sites license for the first six months after the publication date (see <ext-link ext-link-type="uri" xlink:href="http://www.jem.org/misc/terms.shtml">http://www.jem.org/misc/terms.shtml</ext-link>). After six months it is available under a Creative Commons License (Attribution&#x02013;Noncommercial&#x02013;Share Alike 3.0 Unported license, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0/">http://creativecommons.org/licenses/by-nc-sa/3.0/</ext-link>).</license-p></license></permissions><abstract><p>Class switch recombination (CSR) allows the humoral immune response to exploit different effector pathways through specific secondary antibody isotypes. However, the molecular mechanisms and factors that control immunoglobulin (Ig) isotype choice for CSR are unclear. We report that deficiency for the Ikaros transcription factor results in increased and ectopic CSR to IgG<sub>2b</sub> and IgG<sub>2a</sub>, and reduced CSR to all other isotypes, regardless of stimulation. Ikaros suppresses active chromatin marks, transcription, and activation-induced cytidine deaminase (AID) accessibility at the &#x003b3;2b and &#x003b3;2a genes to inhibit class switching to these isotypes. Further, Ikaros directly regulates isotype gene transcription as it directly binds the <italic>Igh</italic> 3&#x02032; enhancer and interacts with isotype gene promoters. Finally, Ikaros-mediated repression of &#x003b3;2b and &#x003b3;2a transcription promotes switching to other isotype genes by allowing them to compete for AID-mediated recombination at the single-cell level. Thus, our results reveal transcriptional competition between constant region genes in individual cells to be a critical and general mechanism for isotype specification during CSR. We show that Ikaros is a master regulator of this competition.</p></abstract></article-meta></front><body><p>Class switch recombination (CSR) diversifies the humoral immune response by joining a single antibody variable region gene with different constant region (C<sub>H</sub>) genes responsible for unique effector functions (<xref ref-type="bibr" rid="bib1">1</xref>). This is crucial for establishing immunity, as patients selectively deficient in CSR suffer from recurrent and severe infections (<xref ref-type="bibr" rid="bib2">2</xref>). CSR occurs between repetitive but nonhomologous DNA sequences called switch (S) regions, which are located upstream of each C<sub>H</sub> gene (except &#x003b4;). CSR requires the expression of activation-induced cytidine deaminase (AID) (<xref ref-type="bibr" rid="bib3">3</xref>, <xref ref-type="bibr" rid="bib4">4</xref>), an enzyme that is thought to directly deaminate single-stranded DNA (<xref ref-type="bibr" rid="bib5">5</xref>, <xref ref-type="bibr" rid="bib6">6</xref>), though this mechanism is still under debate (<xref ref-type="bibr" rid="bib7">7</xref>). DNA lesions induced by AID are processed to generate double-stranded DNA breaks (DSBs), which activate DNA damage response proteins to promote efficient long-range recombination (<xref ref-type="bibr" rid="bib8">8</xref>). DSBs in S&#x003bc; and downstream S regions are ultimately joined through end joining mechanisms, allowing the expression of a new antibody isotype (<xref ref-type="bibr" rid="bib1">1</xref>).</p><p>CSR requires transcription and is targeted to individual constant region genes by the selective activation of isotype-specific intronic (I) promoters in response to antigen, cytokine, and co-stimulatory signals (<xref ref-type="bibr" rid="bib9">9</xref>). This &#x0201c;germline transcription&#x0201d; begins at I exons and proceeds through adjacent S regions and C<sub>H</sub> genes, giving rise to noncoding germline transcripts (GLTs). Transcription is thought to initiate CSR by promoting S region accessibility and exposing single-stranded DNA to AID (<xref ref-type="bibr" rid="bib1">1</xref>). Indeed, CSR is abrogated by I promoter deletions (<xref ref-type="bibr" rid="bib10">10</xref>, <xref ref-type="bibr" rid="bib11">11</xref>) and is restored by their replacement with heterologous promoters (<xref ref-type="bibr" rid="bib12">12</xref>, <xref ref-type="bibr" rid="bib13">13</xref>). These latter studies also demonstrated that constitutively transcribed S regions are ectopically targeted for CSR, highlighting the role of S region transcription in isotype selection. However, the mechanisms establishing this targeting are not completely understood, and it is unclear how individual cells select between simultaneously transcribed S regions for CSR.</p><p>Germline transcription is regulated by an enhancer at the 3&#x02032; end of the <italic>Igh</italic> locus and by chromatin modifications. The 30-kb <italic>Igh</italic> 3&#x02032; enhancer lies downstream of C&#x003b1; and contains four DNase hypersensitive (HS) regions: HS3a, HS1,2, HS3b, and HS4. Disruption of the enhancer reduces transcription and CSR to all isotypes, with &#x003b3;3, &#x003b3;2b, and &#x003b3;2a most drastically affected (<xref ref-type="bibr" rid="bib14">14</xref>, <xref ref-type="bibr" rid="bib15">15</xref>). As the 3&#x02032; enhancer is distant from I promoters (up to 110 kb), transcriptional control is believed to occur through promoter&#x02013;enhancer looping (<xref ref-type="bibr" rid="bib16">16</xref>). In addition, histone modifications, such as histone H3 acetylation (AcH3) at I exons and S regions, are tightly correlated with GLT induction, indicating that they may regulate germline transcription (<xref ref-type="bibr" rid="bib17">17</xref>, <xref ref-type="bibr" rid="bib18">18</xref>). Nonetheless, the molecular mechanisms and factors controlling S region transcription and isotype specification during CSR remain largely undefined.</p><p>The Ikaros zinc finger transcription factor plays important roles in B cells. Ikaros is required for B cell specification (<xref ref-type="bibr" rid="bib19">19</xref>, <xref ref-type="bibr" rid="bib20">20</xref>) and differentiation (<xref ref-type="bibr" rid="bib20">20</xref>&#x02013;<xref ref-type="bibr" rid="bib22">22</xref>), as well as allelic exclusion at the <italic>Ig&#x003ba;</italic> locus (<xref ref-type="bibr" rid="bib23">23</xref>, <xref ref-type="bibr" rid="bib24">24</xref>). We have studied Ikaros function in the B cell lineage using mice bearing a hypomorphic mutation in the <italic>ikzf1</italic> (Ikaros) locus (Ik<sup>L/L</sup>). Ik<sup>L/L</sup> mice contain a LacZ reporter knocked into <italic>ikzf1</italic> exon 2, resulting in the production of low levels of functional, but truncated, Ikaros proteins (&#x0223c;10% of WT) in hematopoietic cells (<xref ref-type="bibr" rid="bib21">21</xref>). Unlike Ikaros-null mice (<xref ref-type="bibr" rid="bib19">19</xref>), Ik<sup>L/L</sup> mice develop relatively normal numbers of mature, polyclonal B cells (<xref ref-type="bibr" rid="bib21">21</xref>). Interestingly, Ik<sup>L/L</sup> mice exhibit abnormal serum antibody titers, characterized by striking &#x0003e;50% reductions in IgG<sub>3</sub> and IgG<sub>1</sub>, and &#x0003e;50% increases in IgG<sub>2b</sub> and IgG<sub>2a</sub> (<xref ref-type="bibr" rid="bib21">21</xref>). This intriguing observation led us to hypothesize that Ikaros plays a role in isotype selection. In this paper, we report that Ikaros is indeed a central regulator of <italic>Igh</italic> locus transcription and isotype specification during CSR.</p><sec sec-type="results"><title>RESULTS</title><sec><title>Ikaros deficiency skews CSR to IgG<sub>2b</sub> and IgG<sub>2a</sub></title><p>To determine if Ikaros regulates CSR, switching to all isotypes was assessed in purified WT and Ik<sup>L/L</sup> splenic B220<sup>+</sup> B cells using a battery of in vitro culture conditions. CSR was measured by flow cytometry (FACS) for surface Ig isotype expression after 3&#x02013;4 d in culture. After LPS stimulation, WT cells switched only to IgG<sub>3</sub> and IgG<sub>2b</sub>, as expected (<xref ref-type="fig" rid="fig1">Fig. 1 A</xref> and <ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20082311/DC1">Fig. S1 A</ext-link>). In contrast, IgG<sub>2b</sub><sup>+</sup> cells were 3.6-fold more frequent in Ik<sup>L/L</sup> cultures, and IgG<sub>2a</sub><sup>+</sup> cells were also detected, whereas IgG<sub>3</sub><sup>+</sup> cells were reduced (23% of WT; <xref ref-type="fig" rid="fig1">Fig. 1 A</xref> and Fig. S1 A). After LPS + IFN-&#x003b3; stimulation, both genotypes switched to the same isotypes, but Ik<sup>L/L</sup> cultures produced more IgG<sub>2b</sub><sup>+</sup> and IgG<sub>2a</sub><sup>+</sup> cells (up 2.3- and 2.7-fold, respectively, vs. WT) and fewer IgG<sub>3</sub><sup>+</sup> cells (24% of WT; <xref ref-type="fig" rid="fig1">Fig. 1 B</xref> and Fig. S1 B). After LPS + IL-4 stimulation, WT cells switched to IgG<sub>1</sub> (<xref ref-type="fig" rid="fig1">Fig. 1 C</xref> and Fig. S1 C) and IgE (as determined by RT&#x02013;quantitative PCR [qPCR] of &#x003f5; postswitch transcripts; <xref ref-type="fig" rid="fig2">Fig. 2 A</xref>) (<xref ref-type="bibr" rid="bib25">25</xref>), as expected. In contrast, Ik<sup>L/L</sup> cells switched ectopically to IgG<sub>2b</sub>, IgG<sub>2a</sub>, and IgG<sub>3</sub>, produced fewer IgG<sub>1</sub><sup>+</sup> cells than WT (WT, 30.1 &#x000b1; 1.63%; Ik<sup>L/L</sup>, 26.2 &#x000b1; 1.57%), and exhibited a 54% reduction in &#x003f5; postswitch transcripts, indicating fewer IgE<sup>+</sup> cells (<xref ref-type="fig" rid="fig1">Fig. 1 C</xref>, <xref ref-type="fig" rid="fig2">Fig. 2 A</xref>, and Fig. S1). After LPS + IL-5 + TGF-&#x003b2; stimulation, WT cells switched to IgG<sub>3</sub>, IgG<sub>2b</sub>, and IgA, whereas Ik<sup>L/L</sup> cultures generated 2.9-fold more IgG<sub>2b</sub><sup>+</sup> cells, unexpected IgG<sub>2a</sub><sup>+</sup> cells, and fewer IgG<sub>3</sub><sup>+</sup> and IgA<sup>+</sup> cells (32 and 52% of WT, respectively; <xref ref-type="fig" rid="fig1">Fig. 1 D</xref> and Fig. S1 D). In all of the these conditions, the fraction of switched cells (e.g., IgG<sup>+</sup> and IgA<sup>+</sup>) in Ikaros-deficient cultures increased 20&#x02013;120% versus WT, suggesting a general increase in switching capacity (<xref ref-type="fig" rid="fig1">Fig. 1</xref>). Finally, we confirmed these results by ELISA (<ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20082311/DC1">Fig. S2</ext-link>), demonstrating that isotype expression is significantly skewed toward IgG<sub>2b</sub> and IgG<sub>2a</sub> in activated Ikaros-deficient B cells.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><p><bold>CSR is skewed toward IgG<sub>2b</sub> and IgG<sub>2a</sub> in Ik<sup>L/L</sup> B cells.</bold> CFSE-labeled B220<sup>+</sup> WT and Ik<sup>L/L</sup> B cells were stimulated for 72 h with (A) LPS, (B) LPS + IFN-&#x003b3;, or (C) LPS + IL-4. (D) 24 h with LPS was followed by 72 h with LPS + IL-5 + TGF-&#x003b2;. CSR was analyzed by FACS, and percentages of Ig<sup>+</sup> cells are indicated. The data are representative of more than four independent experiments. Bar graphs represent mean percentages plus SD of switched cells in each condition for four (D) or five (A&#x02013;C) experiments. Significance was determined by a two-tailed <italic>t</italic> test assuming unequal variance (***, P &#x0003c; 0.005; **, P &#x0003c; 0.02).</p></caption><graphic xlink:href="JEM_20082311_RGB_Fig1"/></fig><fig id="fig2" position="float"><label>Figure 2.</label><caption><p><bold>Reduced IgE switching in Ik<sup>L/L</sup> B cells despite normal &#x003f5; GLT expression.</bold> (A) I&#x003bc;-C&#x003f5; transcript expression in B220<sup>+</sup> WT and Ik<sup>L/L</sup> B cells after 72 h of stimulation with LPS + IL-4 was analyzed by RT-qPCR. The I&#x003bc; promoter is equally active in WT and Ik<sup>L/L</sup> cells (<xref ref-type="fig" rid="fig4">Fig. 4, A&#x02013;D</xref>), indicating that I&#x003bc;-C&#x003f5; transcripts can be faithfully compared between genotypes to quantify IgE-switched cells. (B) RT-qPCR for &#x003f5; GLT expression after 48 h of LPS + IL-4 stimulation. <italic>Ig&#x003b2;</italic> was used as a loading control and all values were normalized to WT. Significance was determined by a two-tailed <italic>t</italic> test assuming unequal variance (**, P &#x0003c; 0.02). Graphs represent means plus SD of two (A) or three (B) independent experiments. Neither I&#x003bc;-C&#x003f5; transcripts nor &#x003f5; GLTs were detected in other conditions (not depicted).</p></caption><graphic xlink:href="JEM_20082311_RGB_Fig2"/></fig><p>Because CSR requires proliferation (<xref ref-type="bibr" rid="bib26">26</xref>) and Ik<sup>L/L</sup> B cells hyperproliferate at low stimuli concentrations and cell densities (<xref ref-type="bibr" rid="bib21">21</xref>), overall increases in switched cells and/or specific increases in IgG<sub>2b</sub><sup>+</sup> and IgG<sub>2a</sub><sup>+</sup> cells could be caused by increased cell divisions in Ik<sup>L/L</sup> cultures. To evaluate this, CFSE dilution was used to track cell division, and the percentage of IgG/A<sup>+</sup> WT and Ik<sup>L/L</sup> cells in each generation was compared for the described conditions. Each generation of Ik<sup>L/L</sup> cells exhibited increases in IgG<sub>2b</sub><sup>+</sup> and IgG<sub>2a</sub><sup>+</sup> cells, as well as increased overall switching after all stimulations when compared with WT; increases in IgG<sub>3</sub><sup>+</sup> cells were also detected after LPS + IL-4 stimulation (<ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20082311/DC1">Fig. S3</ext-link>). Further, Ik<sup>L/L</sup> cells exhibited reduced CSR to IgG<sub>3</sub> and IgA at every division analyzed and to IgG<sub>1</sub> after the third division in conditions that induce WT cells to switch to these isotypes (LPS, LPS + IFN-&#x003b3;, and LPS + IL-5 + TGF-&#x003b2; for IgG<sub>3</sub>, LPS + IL-4 for IgG<sub>1</sub>, and LPS + IL-5 + TGF-&#x003b2; for IgA; Fig. S3). These results indicate that significant, proliferation-independent isotype expression abnormalities exist in Ik<sup>L/L</sup> B cells after CSR-inducing stimulation.</p><p>It was also possible that the increased IgG<sub>2b</sub><sup>+</sup> and IgG<sub>2a</sub><sup>+</sup> populations in Ik<sup>L/L</sup> cultures could be caused by the expansion of autoreactive cells that had previously switched in vivo, rather than specific CSR defects, considering the lower activation thresholds of Ik<sup>L/L</sup> B cells (<xref ref-type="bibr" rid="bib21">21</xref>) and the production of autoantibodies in transgenic mice expressing a B cell&#x02013;restricted dominant-negative Ikaros isoform (<xref ref-type="bibr" rid="bib27">27</xref>). Thus, isotype expression was analyzed using whole and bona fide unswitched B cells (B220<sup>+</sup>, and CD43<sup>&#x02212;</sup>IgG/A<sup>&#x02212;</sup> and CD43<sup>&#x02212;</sup>IgM<sup>+</sup>, respectively) that were stimulated with LPS, LPS + IFN-&#x003b3;, and LPS + IL-4. Regardless of purification strategy, Ik<sup>L/L</sup> cultures exhibited consistent and significant increases in IgG<sub>2b</sub><sup>+</sup> and IgG<sub>2a</sub><sup>+</sup> (and IgG<sub>3</sub><sup>+</sup> with LPS + IL-4) cells compared with WT cultures (<ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20082311/DC1">Fig. S4</ext-link>). Further, there were no significant differences in IgG<sub>2b</sub> or IgG<sub>2a</sub> expression between B220<sup>+</sup>, CD43<sup>&#x02212;</sup>IgG/A<sup>&#x02212;</sup>, and CD43<sup>&#x02212;</sup>IgM<sup>+</sup> Ik<sup>L/L</sup> cultures (Fig. S4). Thus, the aberrant isotype expression by Ikaros-deficient B cells results from defects in CSR and not from the expansion of in vivo&#x02013;switched cells.</p><p>In summary, Ik<sup>L/L</sup> cells (a) are more likely to undergo CSR, (b) display enhanced and ectopic CSR to IgG<sub>2b</sub> and IgG<sub>2a</sub> regardless of stimulation, and (c) show reduced CSR to all other isotypes (except for ectopic CSR to IgG<sub>3</sub> after LPS + IL-4). Therefore, Ikaros deficiency results in a B cell&#x02013;intrinsic defect in isotype specification during CSR.</p></sec><sec><title>Ikaros function is required during CSR</title><p>Because Ikaros is expressed throughout B cell development and controls processes such as V(D)J recombination, which may affect the B cell repertoire (<xref ref-type="bibr" rid="bib19">19</xref>, <xref ref-type="bibr" rid="bib20">20</xref>), we asked if Ikaros is required in mature B cells during CSR. WT B cells were stimulated for 24 h with LPS to induce CSR, and were then transduced with retroviruses encoding the dominant-negative Ikaros 6 (Ik6) isoform and a truncated human nerve growth factor receptor (NGFR) reporter. The Ik6 isoform lacks DNA binding domain zinc fingers and, upon dimerization, inhibits DNA binding by functional Ikaros isoforms (<xref ref-type="bibr" rid="bib28">28</xref>). 72 h after infection, switching and NGFR expression were analyzed by FACS. WT cells transduced with control virus (NGFR<sup>hi</sup>) switched exclusively to IgG<sub>3</sub> and IgG<sub>2b</sub>, as did uninfected cells (NGFR<sup>&#x02212;</sup>) from WT cultures transduced with Ik6-NGFR (<xref ref-type="fig" rid="fig3">Fig. 3</xref>). Ik6-NGFR<sup>hi</sup> cells, however, exhibited a threefold increase in IgG<sub>2b</sub><sup>+</sup> cells, ectopic CSR to IgG<sub>2a</sub>, 30&#x02013;50% fewer IgG<sub>3</sub><sup>+</sup> cells, and more switched cells (<xref ref-type="fig" rid="fig3">Fig. 3</xref> and <ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20082311/DC1">Fig. S5 A</ext-link>). Thus, inhibiting Ikaros function in mature WT B cells during CSR recapitulated the Ik<sup>L/L</sup> switching phenotype. Similarly, transduction of Ik<sup>L/L</sup> cells with the full-length Ik1 isoform rescued Ik<sup>L/L</sup> switching defects (Fig. S5, B and C). Importantly, equally effective rescue was achieved with the truncated Ik1 isoform that lacks exon 2&#x02013;derived protein sequences and is expressed at low levels in Ik<sup>L/L</sup> cells, indicating that these truncated Ikaros proteins function like full-length Ikaros during CSR (Fig. S5, B and C) (<xref ref-type="bibr" rid="bib21">21</xref>). Collectively these results show that Ikaros regulates CSR specificity and efficiency in mature B cells.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><p><bold>Ikaros regulates CSR in mature B cells.</bold> CFSE-stained B220<sup>+</sup> WT B cells were activated for 24 h with LPS to induce CSR, infected with retroviruses encoding the NGFR reporter alone or with the dominant-negative Ik6 isoform (Ik6-NGFR), and stimulated for another 72 h with LPS. Ig and NGFR expression were analyzed by FACS. Numbers represent percentages of NGFR<sup>&#x02212;</sup>, NGFR<sup>+</sup>, or IgG<sup>+</sup> cells. The data are representative of four independent experiments (<ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20082311/DC1">Fig. S5 A</ext-link> provides a statistical analysis).</p></caption><graphic xlink:href="JEM_20082311_RGB_Fig3"/></fig></sec><sec><title>AID expression is normal in Ik<sup>L/L</sup> B cells</title><p>AID protein levels correlate with <italic>aicda</italic> transcript levels and switching efficiency (<xref ref-type="bibr" rid="bib29">29</xref>&#x02013;<xref ref-type="bibr" rid="bib31">31</xref>). Thus, if <italic>aicda</italic>/AID expression were increased in Ikaros-deficient B cells, it could account for increased switching. <italic>Aicda</italic> expression was examined by RT-qPCR in WT and Ik<sup>L/L</sup> B cells, either freshly isolated or stimulated for 48 h with LPS, LPS + IFN-&#x003b3;, or LPS + IL-4. Stimulation of WT and Ik<sup>L/L</sup> B cells induced <italic>aicda</italic> expression &#x0003e;48-fold, and there was no significant difference in <italic>aicda</italic> levels between Ik<sup>L/L</sup> and WT, though expression was slightly higher in mutant cells (<ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20082311/DC1">Fig. S6</ext-link>). Further, multiplex single-cell (SC)&#x02013;RT-PCR analysis revealed similar percentages of <italic>aicda<sup>+</sup></italic> cells in both genotypes after LPS (WT, 71%; Ik<sup>L/L</sup>, 67%) and LPS + IL-4 (WT, 65%; Ik<sup>L/L</sup>, 62%) stimulation, suggesting similar levels of <italic>aicda</italic> transcripts per cell (<ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20082311/DC1">Table S1</ext-link>; see <xref ref-type="fig" rid="fig9">Fig. 9, A and B</xref>). Thus, higher CSR efficiency in Ik<sup>L/L</sup> cells is not caused by increased <italic>aicda</italic> expression.</p></sec><sec><title>Ikaros deficiency results in deregulated S region transcription</title><p>To determine if Ikaros controls CSR specificity by regulating S region transcription, we measured GLT levels for &#x003bc;, &#x003b3;3, &#x003b3;1, &#x003b3;2b, &#x003b3;2a, and &#x003f5; in WT and Ik<sup>L/L</sup> B cells by RT-qPCR. Freshly isolated Ik<sup>L/L</sup> cells exhibited three- to sixfold increases in &#x003b3;3, &#x003b3;2b, and &#x003b3;2a GLT expression at the population level (<xref ref-type="fig" rid="fig4">Fig. 4 A</xref>). Further, SC-RT-PCR revealed that &#x0223c;22 and &#x0223c;6% of Ik<sup>L/L</sup> cells expressed &#x003b3;3 and &#x003b3;2b GLTs, respectively, whereas virtually no WT cells expressed either GLT, suggesting that Ikaros represses the transcription of a subset of S regions in the absence of ex vivo stimulation (<ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20082311/DC1">Fig. S7</ext-link> and Table S1). After 48 h with LPS, LPS + IFN-&#x003b3;, or LPS + IL-4, WT B cells specifically induced GLTs for the isotypes to which they switched (<xref ref-type="fig" rid="fig1">Fig. 1, A&#x02013;C</xref>; and <xref ref-type="fig" rid="fig4">Fig. 4, B&#x02013;D</xref>). Ik<sup>L/L</sup> cells, however, expressed markedly different patterns of GLTs, and only derepressed GLTs correlated well with CSR. Strikingly, &#x003b3;2b and &#x003b3;2a GLTs were either overexpressed (&#x0003e;3.5-fold) or expressed ectopically (&#x003b3;2b with LPS + IL-4, and &#x003b3;2a with LPS and LPS + IL-4) in Ik<sup>L/L</sup> cells, and this expression correlated with increased or ectopic CSR to these isotypes (<xref ref-type="fig" rid="fig1">Fig. 1, A&#x02013;C</xref>; <xref ref-type="fig" rid="fig4">Fig. 4, B&#x02013;D</xref>; and <ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20082311/DC1">Fig. S8</ext-link>). Similarly, &#x003b3;3 GLTs were expressed ectopically with LPS + IL-4 stimulation, which correlated with ectopic IgG<sub>3</sub> switching (<xref ref-type="fig" rid="fig1">Fig. 1 C</xref> and <xref ref-type="fig" rid="fig4">Fig. 4 D</xref>). In contrast, &#x003bc; GLTs were expressed similarly in both genotypes, and surprisingly, despite expressing WT levels of &#x003b3;3 (with LPS and LPS + IFN-&#x003b3;), &#x003b3;1 and &#x003f5; GLTs, Ik<sup>L/L</sup> cells switched less efficiently to these isotypes (<xref ref-type="fig" rid="fig1">Fig. 1, A&#x02013;C</xref>; <xref ref-type="fig" rid="fig2">Fig. 2</xref>; and <xref ref-type="fig" rid="fig4">Fig. 4, B&#x02013;D</xref>). Collectively, these results suggest that Ikaros represses the transcription of S&#x003b3;3, S&#x003b3;2b, and S&#x003b3;2a in resting and stimulated cells, and that increased germline transcription of S&#x003b3;2b and S&#x003b3;2a (and S&#x003b3;3 after LPS + IL-4) in Ikaros-deficient cells skews isotype selection during CSR.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><p><bold>Deregulated expression of &#x003b3;3, &#x003b3;2b, and &#x003b3;2a GLTs in Ik<sup>L/L</sup> B cells.</bold> GLTs expressed by B220<sup>+</sup> WT and Ik<sup>L/L</sup> B cells that were (A) freshly isolated or stimulated for 48 h with (B) LPS, (C) LPS + IFN-&#x003b3;, or (D) LPS + IL-4 were analyzed by qPCR. GLTs were normalized to <italic>Ig&#x003b2;</italic> levels and all values are represented relative to those of unstimulated WT B cells. Graphs represent means plus SD of three independent experiments. Significance was determined by a two-tailed <italic>t</italic> test assuming unequal variance (***, P &#x0003c; 0.005; **, P &#x0003c; 0.02; *, P &#x0003c; 0.05).</p></caption><graphic xlink:href="JEM_20082311_RGB_Fig4"/></fig></sec><sec><title>Derepression of S region transcription in Ik<sup>L/L</sup> cells results in increased AID-dependent histone modifications</title><p>If enhanced S&#x003b3;2b and S&#x003b3;2a transcription skews switching in Ik<sup>L/L</sup> cells, it would be reflected in increased AID accessibility and activity in these S regions, as AID-induced DSBs are necessary intermediates for CSR (<xref ref-type="bibr" rid="bib32">32</xref>). To evaluate AID accessibility, we measured AcH4, which is induced in response to DSBs (<xref ref-type="bibr" rid="bib33">33</xref>, <xref ref-type="bibr" rid="bib34">34</xref>) and is up-regulated in an AID-dependent manner at S regions during CSR (<xref ref-type="bibr" rid="bib18">18</xref>). S region AcH4 levels were analyzed in both freshly isolated and stimulated (48 h) WT and Ik<sup>L/L</sup> cells by chromatin immunoprecipitation (ChIP)&#x02013;qPCR using anti-AcH4 antibodies. S region AcH4 levels were low in unstimulated B cells of both genotypes, as expected (<xref ref-type="fig" rid="fig5">Fig. 5 A</xref>). In WT cells, LPS and LPS + IFN-&#x003b3; induced H4 acetylation at S&#x003b3;3 and S&#x003b3;2b, and LPS + IFN-&#x003b3; also induced AcH4 at S&#x003b3;2a; LPS + IL-4 induced AcH4 exclusively at S&#x003b3;1 (<xref ref-type="fig" rid="fig5">Fig. 5, B&#x02013;D</xref>). Thus, AcH4 levels mirrored GLT and isotype expression in WT cells, confirming that AID-dependent chromatin modifications correlate with transcription and switching (<xref ref-type="fig" rid="fig1">Figs. 1</xref>, <xref ref-type="fig" rid="fig4">4</xref>, and <xref ref-type="fig" rid="fig5">5</xref>) (<xref ref-type="bibr" rid="bib18">18</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><p><bold>AcH4 correlates with transcriptional deregulation in Ik<sup>L/L</sup> B cells.</bold> WT and Ik<sup>L/L</sup> CD43<sup>&#x02212;</sup> B cells that were (A) freshly isolated or stimulated for 48 h with (B) LPS, (C) LPS + IFN-&#x003b3;, or (D) LPS + IL-4 were subjected to ChIP with anti-AcH4 antibodies. Graphs represent the mean S region AcH4 enrichment indexes plus SD for three to four independent experiments. Significance was determined by a two-tailed <italic>t</italic> test assuming unequal variance (***, P &#x0003c; 0.005; **, P &#x0003c; 0.02; *, P &#x0003c; 0.05). AcH4 at S&#x003b3;2a was consistently higher in Ik<sup>L/L</sup> versus WT samples after LPS + IFN-&#x003b3; (S&#x003b3;2a Ik<sup>L/L</sup>/WT ratio mean = 1.68; range = 1.21&#x02013;2.13).</p></caption><graphic xlink:href="JEM_20082311_RGB_Fig5"/></fig><p>In Ik<sup>L/L</sup> cells, however, histone H4 was hyperacetylated at ectopically and overtranscribed S regions. AcH4 levels were consistently higher at S&#x003b3;2b and S&#x003b3;2a in stimulated Ik<sup>L/L</sup> cells compared with WT, correlating with increased transcription and switching to these isotypes (<xref ref-type="fig" rid="fig1">Fig. 1, A&#x02013;C</xref>; <xref ref-type="fig" rid="fig4">Fig. 4, B&#x02013;D</xref>; and <xref ref-type="fig" rid="fig5">Fig. 5, B&#x02013;D</xref>). Similarly, ectopic AcH4 at S&#x003b3;3 in LPS + IL-4&#x02013;stimulated Ik<sup>L/L</sup> cells mirrored ectopic &#x003b3;3 transcription and switching (<xref ref-type="fig" rid="fig1">Fig. 1 C</xref>, <xref ref-type="fig" rid="fig4">Fig. 4 D</xref>, and <xref ref-type="fig" rid="fig5">Fig. 5 D</xref>). In contrast, normal &#x003b3;3 GLT expression in LPS- and LPS + IFN-&#x003b3;&#x02013;stimulated Ik<sup>L/L</sup> cells induced 25&#x02013;40% lower AcH4 levels at S&#x003b3;3 in comparison with WT, suggesting reduced AID-dependent activity (<xref ref-type="fig" rid="fig4">Fig. 4, B and C</xref>; and <xref ref-type="fig" rid="fig5">Fig. 5, B and C</xref>). Finally, similar &#x003b3;1 GLT levels in LPS + IL-4&#x02013;stimulated Ik<sup>L/L</sup> and WT cells resulted in comparable induction of AcH4 at S&#x003b3;1 in both genotypes (<xref ref-type="fig" rid="fig4">Fig. 4 D</xref> and <xref ref-type="fig" rid="fig5">Fig. 5 D</xref>). Thus, increased transcription of S&#x003b3;2b and S&#x003b3;2a (and S&#x003b3;3 after LPS + IL-4) correlates with increased AID-dependent H4 acetylation, suggesting that abnormal germline transcription in Ik<sup>L/L</sup> cells increases AID accessibility at S&#x003b3;2b and S&#x003b3;2a (and S&#x003b3;3) to skew CSR.</p></sec><sec><title>Ikaros does not repress germline transcription by regulating promoter&#x02013;enhancer interactions in the <italic>Igh</italic> locus</title><p>Germline transcription of S&#x003b3;3, S&#x003b3;2b, and S&#x003b3;2a requires the <italic>Igh</italic> 3&#x02032; enhancer (<xref ref-type="bibr" rid="bib14">14</xref>, <xref ref-type="bibr" rid="bib15">15</xref>), and Ikaros has been reported to regulate long-range promoter&#x02013;enhancer looping at the &#x003b2;-globin locus (<xref ref-type="bibr" rid="bib35">35</xref>). Therefore, we asked if Ikaros regulates germline transcription by controlling interactions between the 3&#x02032; enhancer and C<sub>H</sub> gene promoters. <italic>Igh</italic> locus promoter&#x02013;enhancer interactions were assayed in WT and Ik<sup>L/L</sup> B cells by chromosome conformation capture (3C) to measure interactions between distal chromosome regions (<xref ref-type="bibr" rid="bib36">36</xref>). In these experiments, interacting chromatin was cross-linked with formaldehyde, digested with a restriction enzyme, and subjected to intramolecular DNA ligation and qPCR amplification of ligation products (<ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20082311/DC1">Fig. S9</ext-link> shows digestion and PCR controls). We examined interactions between a HindIII fragment containing the HS1,2 regulatory site and fragments covering the &#x003bc; enhancer, downstream C<sub>H</sub> gene promoters, HS3a, and HS3b/4, as well as I regions not expected to participate in the regulation of germline transcription. Although HS1,2 was chosen as a reference point, patterns of promoter&#x02013;enhancer cross-linking were similar, though weaker, using a 3&#x02032; enhancer fragment containing HS3b/4 (unpublished data). WT and Ik<sup>L/L</sup> B cells were compared, either before or after 36 h of stimulation, when germline transcription was efficiently induced, but CSR was barely detectable by FACS (unpublished data). B cell&#x02013;specific interactions were identified by comparison with PMA-stimulated T cells in which the <italic>Igh</italic> locus is silent.</p><p>In freshly isolated B cells, but not T cells, HS1,2 was frequently cross-linked to a fragment containing the &#x003bc; enhancer, as previously reported (<xref ref-type="fig" rid="fig6">Fig. 6 A</xref>) (<xref ref-type="bibr" rid="bib16">16</xref>). This interaction was reduced but still present in Ik<sup>L/L</sup> B cells, suggesting that Ikaros contributes to &#x003bc;&#x02013;3&#x02032; enhancer interactions (<xref ref-type="fig" rid="fig6">Fig. 6 A</xref>). Cross-linking between HS1,2 and &#x003b3;3 or &#x003b3;2a in Ik<sup>L/L</sup> B cells was similar to WT, despite ectopic &#x003b3;3, &#x003b3;2b, and &#x003b3;2a transcription; only HS1,2&#x02013;&#x003b3;2b interactions were increased in mutant cells (<xref ref-type="fig" rid="fig4">Fig. 4 A</xref> and <xref ref-type="fig" rid="fig6">Fig. 6 A</xref>). Thus no clear correlation was detected between C<sub>H</sub> promoter&#x02013;HS1,2 interactions and increased GLT expression in unstimulated Ik<sup>L/L</sup> cells.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><p><bold>Ikaros does not regulate interactions between HS1,2 and C<sub>H</sub> gene promoters.</bold> CD43<sup>&#x02212;</sup> WT and Ik<sup>L/L</sup> B cells were analyzed by 3C, either (A) before or after 36 h with (B) LPS, (C) LPS + IFN-&#x003b3;, or (D) LPS + IL-4. CD4<sup>+</sup> T cells stimulated for 36 h with PMA served as a negative control. The y axis represents the relative cross-linking frequency between a HindIII fragment covering HS1,2 and the rest of the locus. Points represent means plus SD of two independent experiments. Significance was determined by a two-tailed <italic>t</italic> test assuming unequal variance (***, P &#x0003c; 0.005; **, P &#x0003c; 0.02; *, P &#x0003c; 0.05). In A, HS1,2&#x02013;HS3a and &#x02013;HS3b/4 cross-linking frequencies in B cells, though similar between genotypes, were too high to be shown.</p></caption><graphic xlink:href="JEM_20082311_RGB_Fig6"/></fig><p>Next, we asked if Ikaros deficiency affects promoter&#x02013;enhancer interactions after stimulation. In LPS-induced WT cells, there were B cell&#x02013;specific HS1,2&#x02013;&#x003b3;3 and &#x02013;&#x003b3;2b cross-linking peaks, indicating HS1,2 interactions with these C<sub>H</sub> genes during transcription and switching (<xref ref-type="fig" rid="fig1">Fig. 1 A</xref>, <xref ref-type="fig" rid="fig4">Fig. 4 B</xref>, and <xref ref-type="fig" rid="fig6">Fig. 6 B</xref>). In Ik<sup>L/L</sup> cells, HS1,2&#x02013;&#x003b3;2b and &#x02013;&#x003b3;2a cross-linking frequencies were similar to WT despite enhanced germline transcription of these genes (<xref ref-type="fig" rid="fig4">Fig. 4 B</xref> and <xref ref-type="fig" rid="fig6">Fig. 6 B</xref>); HS1,2&#x02013;&#x003b3;3 interactions were also similar between genotypes. After LPS + IFN-&#x003b3; stimulation, WT cells exhibited significant B cell&#x02013;specific cross-linking between HS1,2 and &#x003b3;2a, as well as interaction peaks between HS1,2 and &#x003b3;3 and &#x003b3;2b, which correlated with transcription and switching for all three genes (<xref ref-type="fig" rid="fig1">Fig. 1 B</xref>, <xref ref-type="fig" rid="fig4">Fig. 4 C</xref>, and <xref ref-type="fig" rid="fig6">Fig. 6 C</xref>). HS1,2&#x02013;&#x003b3;2b and &#x02013;&#x003b3;2a interactions were nearly identical in Ik<sup>L/L</sup> cells, despite sharply increased transcription and switching mainly to &#x003b3;2a and, to a lesser extent, &#x003b3;2b and &#x003b3;3 (<xref ref-type="fig" rid="fig1">Fig. 1 B</xref>, <xref ref-type="fig" rid="fig4">Fig. 4 C</xref>, and <xref ref-type="fig" rid="fig6">Fig. 6 C</xref>). On the other hand, HS1,2&#x02013;&#x003b3;3 interactions were somewhat, but not significantly reduced in Ik<sup>L/L</sup> cells (despite normal transcription), indicating a possible role for Ikaros in HS1,2&#x02013;&#x003b3;3 interactions after LPS + IFN-&#x003b3; (<xref ref-type="fig" rid="fig6">Fig. 6 C</xref>). Finally, LPS + IL-4 induced consistently higher HS1,2&#x02013;&#x003b3;1 interactions in WT and Ik<sup>L/L</sup> B cells versus WT T cells, which correlated with transcription and switching at &#x003b3;1 in response to LPS + IL-4, as previously reported (<xref ref-type="fig" rid="fig1">Fig. 1 C</xref>, <xref ref-type="fig" rid="fig4">Fig. 4 D</xref>, and <xref ref-type="fig" rid="fig6">Fig. 6 D</xref>) (<xref ref-type="bibr" rid="bib16">16</xref>). Importantly, ectopic transcription of &#x003b3;3, &#x003b3;2b, and &#x003b3;2a in LPS + IL-4&#x02013;stimulated Ik<sup>L/L</sup> cells did not correlate with modified promoter&#x02013;enhancer interactions, as there were no significant differences between WT and Ik<sup>L/L</sup> cells, and only HS1,2&#x02013;&#x003b3;2a cross-linking was slightly increased in mutant populations (<xref ref-type="fig" rid="fig4">Fig. 4 D</xref> and <xref ref-type="fig" rid="fig6">Fig. 6 D</xref>). In summary, similar to previous reports, we found interactions between HS1,2 and C<sub>H</sub> genes that were transcribed and targeted for CSR in WT cells (<xref ref-type="bibr" rid="bib16">16</xref>). Further, there was no clear correlation between C<sub>H</sub> promoter&#x02013;HS1,2 interactions and defects in germline transcription. Therefore, deregulated S region transcription and aberrant switching in Ikaros-deficient B cells is not caused by altered interactions between the <italic>Igh</italic> 3&#x02032; enhancer and the promoters of specific C<sub>H</sub> genes.</p></sec><sec><title>Ikaros maintains repressive chromatin at the &#x003b3;2b and &#x003b3;2a genes</title><p>AcH3 is a hallmark of transcriptionally active chromatin (<xref ref-type="bibr" rid="bib37">37</xref>) and correlates tightly with germline transcription (<xref ref-type="bibr" rid="bib17">17</xref>, <xref ref-type="bibr" rid="bib18">18</xref>). Thus, we asked if Ikaros could regulate S region transcription by controlling H3 acetylation. AcH3 was examined at C&#x003b3; I exons and S regions in WT and Ik<sup>L/L</sup> B cells by ChIP-qPCR, both before and after 48 h of stimulation. There were no significant differences in AcH3 levels between freshly isolated WT and Ik<sup>L/L</sup> cells (<xref ref-type="fig" rid="fig7">Fig. 7 A</xref>). This suggests that AcH3 levels either do not contribute to GLT overexpression, or that our assay lacked the sensitivity required to detect differences in AcH3 associated with low levels of transcription (<xref ref-type="fig" rid="fig4">Fig. 4 A</xref>).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><p><bold>Increased AcH3 at &#x003b3;3, &#x003b3;2b, and &#x003b3;2a in Ik<sup>L/L</sup> B cells.</bold> WT and Ik<sup>L/L</sup> CD43<sup>&#x02212;</sup> B cells that were (A) freshly isolated or stimulated for 48 h with (B) LPS, (C) LPS + IFN-&#x003b3;, or (D) LPS + IL-4 were subjected to ChIP with anti-AcH3 antibodies. Graphs represent the mean I exon (I) and S region (S) AcH3 enrichment indexes plus SD for three independent experiments. Significance was determined by a two-tailed <italic>t</italic> test assuming unequal variance (***, P &#x0003c; 0.005; **, P &#x0003c; 0.02; *, P &#x0003c; 0.05). S&#x003b3;2b and S&#x003b3;2a AcH3 levels were consistently higher in Ik<sup>L/L</sup> versus WT samples after LPS + IFN-&#x003b3; (S&#x003b3;2b Ik<sup>L/L</sup>/WT ratio mean = 2.68 [range = 1.82&#x02013;3.47]; S&#x003b3;2a Ik<sup>L/L</sup>/WT ratio mean = 2.41 [range = 1.45&#x02013;3.87]).</p></caption><graphic xlink:href="JEM_20082311_RGB_Fig7"/></fig><p>Next, we determined if AcH3 levels correlate with deregulated germline transcription in Ik<sup>L/L</sup> B cells after stimulation. Stimulated WT cells induced H3 acetylation at the isotype genes they transcribed: I/S&#x003b3;3 and I/S&#x003b3;2b with LPS and LPS + IFN-&#x003b3;, I/S&#x003b3;2a with LPS + IFN-&#x003b3;, and I/S&#x003b3;1 with LPS + IL-4 (<xref ref-type="fig" rid="fig4">Fig. 4, B&#x02013;D</xref>; and <xref ref-type="fig" rid="fig7">Fig. 7, B&#x02013;D</xref>). Strikingly, in stimulated Ik<sup>L/L</sup> cells, AcH3 levels at the &#x003b3;2b and &#x003b3;2a I exons and/or S regions were consistently higher than in WT cells, and correlated with increased and ectopic transcription (<xref ref-type="fig" rid="fig4">Fig. 4, B&#x02013;D</xref>; and <xref ref-type="fig" rid="fig7">Fig. 7, B&#x02013;D</xref>). Similarly, ectopic AcH3 at I/S&#x003b3;3 in LPS + IL-4&#x02013;stimulated Ik<sup>L/L</sup> cells correlated with ectopic transcription of that isotype (<xref ref-type="fig" rid="fig4">Fig. 4 D</xref> and <xref ref-type="fig" rid="fig7">Fig. 7 D</xref>). Normal levels of &#x003b3;3 (LPS and LPS + IFN-&#x003b3;) and &#x003b3;1 (LPS + IL-4) transcription in Ik<sup>L/L</sup> cells were associated with AcH3 levels at I/S&#x003b3;3 and I/S&#x003b3;1 that were equivalent to WT (<xref ref-type="fig" rid="fig4">Fig. 4, B&#x02013;D</xref>; and <xref ref-type="fig" rid="fig7">Fig. 7, B&#x02013;D</xref>). Importantly, AcH3 enrichment at the 3&#x02032; enhancer was also similar between WT and Ik<sup>L/L</sup> cells (unpublished data). Thus, deregulated transcription and AcH3 are tightly correlated in Ik<sup>L/L</sup> cells, indicating that Ikaros promotes a repressive chromatin state (e.g., histone H3 hypoacetylation) at C<sub>H</sub> promoters and genes during CSR.</p></sec><sec><title>Ikaros interacts directly with the <italic>Igh</italic> locus</title><p>We next asked if Ikaros could control chromatin remodeling and S region transcription through direct binding to <italic>Igh</italic> regulatory regions. We analyzed Ikaros binding to the <italic>Igh</italic> locus in freshly isolated and stimulated WT B cells by ChIP-qPCR using anti-Ikaros antibodies. We focused on regions in the <italic>Igh</italic> 3&#x02032; enhancer and C&#x003b3; gene promoters, I exons and S regions, that contained Ikaros consensus sites identified with the TFSEARCH algorithm (<xref ref-type="bibr" rid="bib38">38</xref>).</p><p>Ikaros associated with the <italic>Igh</italic> locus in vivo in WT B cells (<xref ref-type="fig" rid="fig8">Fig. 8</xref>). In freshly isolated CD43<sup>&#x02212;</sup> cells, Ikaros associated with I&#x003b3;2b and HS1,2 in the 3&#x02032; enhancer (<xref ref-type="fig" rid="fig8">Fig. 8 A</xref>). These associations were maintained after LPS stimulation (<xref ref-type="fig" rid="fig8">Fig. 8 B</xref>). When cells were stimulated with LPS + IFN-&#x003b3;, Ikaros associated at low levels with I&#x003b3;3 and at higher levels with I&#x003b3;2b, I&#x003b3;2a, and HS1,2 (<xref ref-type="fig" rid="fig8">Fig. 8 C</xref>). Interestingly, this stimulation also induced transcription at I&#x003b3;3, I&#x003b3;2b, and I&#x003b3;2a, indicating that Ikaros associates strongly with some I exons upon their transcriptional activation (<xref ref-type="fig" rid="fig8">Fig. 8 C</xref>). Similarly, after LPS + IL-4 stimulation, Ikaros associated with the transcribed I&#x003b3;1 exon (<xref ref-type="fig" rid="fig4">Fig. 4 D</xref> and <xref ref-type="fig" rid="fig8">Fig. 8 D</xref>). In addition, there was moderate Ikaros association with I&#x003b3;2b, whereas the HS1,2 peak remained high (<xref ref-type="fig" rid="fig8">Fig. 8 D</xref>). Thus, Ikaros strongly associates with HS1,2 regardless of stimulation, with I&#x003b3;2b in all conditions but most strongly when I&#x003b3;2b is normally transcribed in WT, and with I&#x003b3;3, I&#x003b3;1, and I&#x003b3;2a when they are transcriptionally induced upon stimulation.</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><p><bold>Ikaros associates with C<sub>H</sub> promoters and HS1,2 of the 3&#x02032; enhancer.</bold> WT CD43<sup>&#x02212;</sup> B cells that were (A) freshly isolated or stimulated for 48 h with (B) LPS, (C) LPS + IFN-&#x003b3;, or (D) LPS + IL-4 were subjected to ChIP-qPCR with anti-Ikaros antibodies. Points represent mean Ikaros enrichment, measured as percentage input, plus SD from two to three independent experiments. Approximate amplicon positions relative to transcription start sites or the 5&#x02032; ends of HS sites are indicated. Dashed lines represent the mean percentage input for each condition and are defined as the threshold of specific Ikaros binding. (E and F) EMSAs were performed on putative Ikaros binding sites from sequences identified by ChIP (A&#x02013;D). (E) Nuclear extracts from Cos cells transduced with an empty vector (V) or one encoding the Ik1 isoform (Ik) were incubated with the indicated probes (<ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20082311/DC1">Table S2</ext-link>). Two putative I&#x003b3;1 Ikaros binding sites were tested. (F) The HS1,2 probe was incubated with nuclear extracts from WT or Ik<sup>L/L</sup> B cells stimulated for 36 h with LPS (L), LPS + IL-4 (<xref ref-type="bibr" rid="bib4">4</xref>), or LPS + IFN-&#x003b3; (I). Specificity was verified by supershift with anti-Ikaros antibodies. Arrowheads indicate Ikaros complexes. Data in E and F are representative of two independent experiments.</p></caption><graphic xlink:href="JEM_20082311R_RGB_Fig8"/></fig><p>To determine if Ikaros binds directly to any of these sequences, we performed EMSA. Exogenous Ikaros, confirmed by supershift, bound strongly to a probe containing a putative Ikaros binding site from HS1,2 (<xref ref-type="fig" rid="fig8">Fig. 8 E</xref>). Interestingly, endogenous Ikaros complexes also bound this probe, indicating that Ikaros can directly bind HS1,2 (<xref ref-type="fig" rid="fig8">Fig. 8 F</xref>). In contrast, Ikaros did not bind to putative sites from I&#x003b3;2b or I&#x003b3;2a, and supershift with Ikaros-specific antibodies revealed only low affinity binding to sites in I&#x003b3;1, in keeping with a previous report (<xref ref-type="fig" rid="fig8">Fig. 8 E</xref>) (<xref ref-type="bibr" rid="bib39">39</xref>). Collectively, these results indicate that Ikaros regulates germline transcription by binding directly to HS1,2, but suggest that its association with I&#x003b3; regions is indirect, possibly through enhancer&#x02013;promoter interactions.</p></sec><sec><title>Ikaros controls transcriptional competition between S regions</title><p>The data described in the previous sections demonstrate that increased and ectopic transcription of &#x003b3;2b and &#x003b3;2a (and &#x003b3;3 with LPS + IL-4) in Ik<sup>L/L</sup> cells correlates with enhanced/ectopic switching to these isotypes. Paradoxically, CSR to IgG<sub>3</sub>, IgG<sub>1</sub>, and IgE is decreased in Ik<sup>L/L</sup> cells despite normal GLT levels (<xref ref-type="fig" rid="fig1">Figs. 1</xref>, <xref ref-type="fig" rid="fig2">2</xref>, and <xref ref-type="fig" rid="fig4">4</xref>). We hypothesized that this discrepancy was caused by increased/ectopic transcription of S&#x003b3;2b/S&#x003b3;2a (and S&#x003b3;3) outcompeting transcription of other S regions for AID-mediated CSR. This model would require that (a) S regions are cotranscribed in individual cells and (b) transcription of S&#x003b3;2b/S&#x003b3;2a (and S&#x003b3;3 with LPS + IL-4) is selectively increased relative to that of other S regions. To test this hypothesis, we examined the expression of <italic>aicda</italic>, and &#x003b3;3 and &#x003b3;2b GLTs (and <italic>actb</italic> as a positive control) by SC-RT-PCR in LPS- and LPS + IL-4&#x02013;stimulated (48 h) IgM<sup>+</sup> cells (<xref ref-type="fig" rid="fig9">Fig. 9</xref> and Table S1). Importantly, because interallelic CSR occurs efficiently in WT cells (<xref ref-type="bibr" rid="bib40">40</xref>, <xref ref-type="bibr" rid="bib41">41</xref>), SC-RT-PCR was performed without regard for allele. In LPS-stimulated WT cells, 97.1% of switching competent cells (e.g., <italic>aicda</italic><sup>+</sup>) expressed GLTs for &#x003b3;2b (90.1%) and/or &#x003b3;3 (78.5%), which correlated with switching to these two isotypes (<xref ref-type="fig" rid="fig1">Fig. 1 A</xref>; and <xref ref-type="fig" rid="fig9">Fig. 9, B and C</xref>). Interestingly, 91.7% of &#x003b3;3 GLT<sup>+</sup> cells also transcribed &#x003b3;2b, whereas 15&#x02013;20% of WT cells switched to IgG<sub>3</sub> after 4 d, indicating that the majority of WT cells cotranscribe S regions and that cells cotranscribing &#x003b3;2b and &#x003b3;3 can still choose &#x003b3;3 for CSR (<xref ref-type="fig" rid="fig3">Fig. 3</xref> and <xref ref-type="fig" rid="fig9">Fig. 9 C</xref>). In LPS + IL-4&#x02013;stimulated cells, the high efficiency of IgG<sub>1</sub> switching suggests that &#x003b3;1 GLTs are expressed in almost all cells (<xref ref-type="fig" rid="fig1">Fig. 1 C</xref>); &#x003b3;1 PCRs were not performed because of the added complexity of performing a fifth PCR in multiplex. Interestingly, 53.9% of <italic>aicda</italic><sup>+</sup> WT cells expressed GLTs for &#x003b3;3 (34.3%) and/or &#x003b3;2b (29.8%), suggesting competition with S&#x003b3;1 in a subset of WT cells (<xref ref-type="fig" rid="fig9">Fig. 9, B and C</xref>). However, by combining SC-RT-PCR and RT-qPCR data (<xref ref-type="fig" rid="fig4">Fig. 4, B and D</xref>), we calculated that the levels of S&#x003b3;3 and S&#x003b3;2b transcripts per &#x003b3;2b<sup>+</sup>/&#x003b3;3<sup>+</sup> cell were four times lower in LPS + IL-4&#x02013;stimulated WT cells than in cells stimulated with LPS (<xref ref-type="fig" rid="fig9">Fig. 9 D</xref>). These low levels appear insufficient to induce CSR to &#x003b3;2b and &#x003b3;2a (<xref ref-type="fig" rid="fig1">Fig. 1 C</xref>). Thus, S regions are cotranscribed in WT cells and relative S region transcription rates per cell correlate with CSR, indicating that S region competition can occur under normal conditions and may regulate isotype choice.</p><fig id="fig9" position="float"><label>Figure 9.</label><caption><p><bold>Increased S region competition at the SC level for CSR in Ik<sup>L/L</sup> B cells.</bold> SC-RT-PCR was performed on IgM<sup>+</sup> WT and Ik<sup>L/L</sup> cells after 48 h of stimulation and two divisions (assessed by CFSE dilution). (A and B) Representative data from cohorts of (A) LPS- and (B) LPS + IL-4&#x02013;stimulated cells are shown. Only <italic>actb<sup>+</sup></italic> wells were counted (positive control for sorting). Bar graphs represent mean percentages plus SD of cells positive for <italic>Aicda,</italic> or &#x003b3;3 or &#x003b3;2b GLTs, from two independent experiments (0, no cells; 1, one cell; raw data are shown in <ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20082311/DC1">Table S1</ext-link>). (C) Pie charts represent mean percentages of <italic>aicda<sup>+</sup></italic> cells expressing GLTs for &#x003b3;3, &#x003b3;2b, both, or neither. The numbers of <italic>aicda<sup>+</sup></italic> cells analyzed over two experiments are indicated (chart centers). (D) Data from C was integrated with GLT expression levels measured by RT-qPCR (<xref ref-type="fig" rid="fig4">Fig. 4, B and D</xref>) to give a comprehensive view of &#x003b3;2b and &#x003b3;3 GLT expression in individual cells. Pie chart wedges represent the percentages of <italic>aicda<sup>+</sup></italic> B cells that express the indicated GLTs. Wedge radii are defined such that the wedge area corresponds to total GLT expression levels; &#x003b3;3 and &#x003b3;2b GLT levels were normalized to LPS-stimulated WT B cells, for which the radius was set to 1. Thus, the percentage of degrees out of 360 taken by each wedge corresponds to the percentage of expressing cells, and the wedge area corresponds to the integrated per cell expression level.</p></caption><graphic xlink:href="JEM_20082311_RGB_Fig9"/></fig><p>S region competition is increased in Ikaros-deficient B cells. After LPS stimulation, virtually every <italic>aicda</italic><sup>+</sup> Ik<sup>L/L</sup> cell expressed &#x003b3;2b GLTs (99.1% &#x003b3;2b GLT<sup>+</sup> cells), whereas the frequency of cells expressing &#x003b3;3 GLTs was slightly lower than in WT (64.3% of Ik<sup>L/L</sup> cells, down 14%; <xref ref-type="fig" rid="fig9">Fig. 9 A</xref>). Strikingly, every &#x003b3;3 GLT<sup>+</sup> Ik<sup>L/L</sup> cell also expressed &#x003b3;2b GLTs, putting S&#x003b3;3 in constant competition with S&#x003b3;2b (<xref ref-type="fig" rid="fig9">Fig. 9 C</xref>). Unlike in WT cells, however, S&#x003b3;3/S&#x003b3;2b cotranscription in Ik<sup>L/L</sup> cells was associated with strongly skewed CSR to IgG<sub>2b</sub> (<xref ref-type="fig" rid="fig1">Fig. 1 A</xref>). To explain this difference, we examined per cell transcript levels and found that &#x003b3;2b GLTs were expressed at 8.5 times higher levels per &#x003b3;2b<sup>+</sup> cell in Ik<sup>L/L</sup> versus WT cultures, whereas &#x003b3;3 GLT levels were similar on a per cell basis (up 1.6-fold in Ik<sup>L/L</sup> vs. WT; <xref ref-type="fig" rid="fig9">Fig. 9 D</xref>). Thus, although both WT and Ik<sup>L/L</sup> B cells cotranscribe S&#x003b3;3/S&#x003b3;2b, increased S&#x003b3;2b transcription in Ik<sup>L/L</sup> cells coincides with IgG<sub>2b</sub>-skewed switching, indicating that higher S&#x003b3;2b transcription outcompetes S&#x003b3;3 transcription for AID-mediated CSR.</p><p>Similarly increased competition was found after LPS + IL-4 stimulation. 91.0% of <italic>aicda</italic><sup>+</sup> Ik<sup>L/L</sup> cells expressed &#x003b3;3 (57.2%, up 22.9%) and/or &#x003b3;2b (83.8%, up 50.8%) GLTs, indicating that these S regions directly compete with S&#x003b3;1 for CSR in most cells (<xref ref-type="fig" rid="fig9">Fig. 9, B and C</xref>). In addition, LPS + IL-4&#x02013;stimulated Ik<sup>L/L</sup> cells expressed &#x003b3;3 and &#x003b3;2b GLTs at per cell levels that were three- to fourfold higher than those found in similarly stimulated WT cells, and nearly equivalent to those observed in LPS-stimulated WT cells (<xref ref-type="fig" rid="fig9">Fig. 9 D</xref>). This correlated with ectopic CSR to these isotypes and reduced CSR to IgG<sub>1</sub> (<xref ref-type="fig" rid="fig1">Fig. 1 C</xref>). Thus, in LPS + IL-4&#x02013;stimulated Ik<sup>L/L</sup> cells, high levels of S&#x003b3;2b/S&#x003b3;3 transcription successfully compete with transcription of S&#x003b3;1 for CSR.</p><p>Collectively, these observations demonstrate that the majority of B cells cotranscribe S regions, and that per cell transcription rates correlate with isotype selection. Further, our results strongly support the hypothesis that increased transcription of S&#x003b3;2b and S&#x003b3;2a (and S&#x003b3;3 with LPS + IL-4) in Ik<sup>L/L</sup> cells outcompetes transcription of other S regions for CSR and thus skews isotype selection.</p></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>In this study, we identify Ikaros as a critical regulator of Ig isotype selection in B cells during CSR. Ikaros deficiency results in increased and ectopic switching to IgG<sub>2b</sub> and IgG<sub>2a</sub> (and ectopic switching to IgG<sub>3</sub> with LPS + IL-4) and enhanced overall switching, but reduced switching to IgG<sub>3</sub> (with LPS and LPS + IFN-&#x003b3;), IgG<sub>1</sub>, IgE, and IgA. This function is independent of Ikaros&#x02019;s role in B cell development, as inhibition of Ikaros in mature WT cells skews isotype selection to IgG<sub>2b</sub> and IgG<sub>2a</sub>, whereas retroviral expression of Ikaros in Ik<sup>L/L</sup> B cells rescues CSR. Further, in direct correlation with their CSR phenotype, Ik<sup>L/L</sup> cells exhibit sharp increases in transcription and AcH4, an AID-dependent histone mark, at S&#x003b3;2b and S&#x003b3;2a (and S&#x003b3;3 with LPS + IL-4) but not other S regions. Ikaros directly binds the <italic>Igh</italic> locus in vivo and is required to prevent hyperacetylation of histone H3 at the &#x003b3;2b and &#x003b3;2a (and &#x003b3;3 with LPS + IL-4) genes upon B cell activation. Thus, Ikaros maintains repressive chromatin at &#x003b3;2b and &#x003b3;2a (and &#x003b3;3 with LPS + IL-4), and suppresses transcription, AID accessibility, and switching to these isotypes. These results identify Ikaros as the first factor that controls the range of isotypes targeted by CSR.</p><p>Our results also reveal that the choice to undergo CSR to specific C<sub>H</sub> genes is controlled by the balance of germline transcription across different S regions within individual cells. We have shown that the majority of <italic>aicda</italic><sup>+</sup> LPS-stimulated WT cells coexpress GLTs for &#x003b3;2b and &#x003b3;3, suggesting competition between these two isotypes for switching. Further, selective increases in &#x003b3;2b GLTs in Ik<sup>L/L</sup> cells, where &#x003b3;3 is always cotranscribed with &#x003b3;2b, correlate with increased CSR to IgG<sub>2b</sub> and decreased CSR to IgG<sub>3</sub>. Thus, repression of S&#x003b3;2b transcription by Ikaros is required to maintain a balance between S&#x003b3;2b and S&#x003b3;3 transcription, allowing for normal switching to both isotypes. Similarly, Ikaros fine tunes S&#x003b3;2b and S&#x003b3;2a transcription in response to LPS + IFN-&#x003b3;, to allow switching to IgG<sub>3</sub>. Therefore, in addition to suppressing promiscuous switching to IgG<sub>3/2b/2a</sub> in response to LPS + IL-4, and IgG<sub>2a</sub> in response to LPS, Ikaros limits transcription across S&#x003b3;2b and S&#x003b3;2a so that germline transcription of other S regions (i.e., S&#x003b3;3 and S&#x003b1;) can effectively compete for switching. These results indicate that the isotype fate of individual cells during CSR is determined by the relative levels of germline transcription across different S regions. Considering that single human B cells have also been reported to transcribe multiple S regions simultaneously (<xref ref-type="bibr" rid="bib42">42</xref>), this is likely a general mechanism, across species, for isotype selection during CSR.</p><p>A question arising from our work is how Ikaros suppresses transcription at &#x003b3;3, &#x003b3;2b, and &#x003b3;2a. Interestingly, we have found that histone H3 is hyperacetylated at these genes in Ik<sup>L/L</sup> cells. Although it is possible that these increased AcH3 levels result from transcription-coupled processes, it is attractive to speculate that Ikaros regulates germline transcription by maintaining a repressive chromatin structure. In this respect, it is well documented that histone acetylation contributes to transcription by opening chromatin and/or providing binding platforms for regulatory factors (<xref ref-type="bibr" rid="bib43">43</xref>, <xref ref-type="bibr" rid="bib44">44</xref>).</p><p>Considering that H3 is hyperacetylated in Ik<sup>L/L</sup> cells and that Ikaros interacts with the Sin3 and NuRD histone deacetylase (HDAC) complexes (<xref ref-type="bibr" rid="bib45">45</xref>&#x02013;<xref ref-type="bibr" rid="bib48">48</xref>), we expected Ikaros to recruit these complexes to the <italic>Igh</italic> locus to regulate germline transcription. However, we have been unable to find reduced <italic>Igh</italic> locus occupancy for Sin3a, Mi-2&#x003b2; (a core member of NuRD), HDAC1, or HDAC2 in Ik<sup>L/L</sup> versus WT cells by ChIP-qPCR or double cross-linking (DC)&#x02013;ChIP-qPCR (<ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20082311/DC1">Fig. S10</ext-link>). Furthermore, shRNA knockdown of Mi-2&#x003b2; in WT B cells neither increased &#x003b3;2b transcription nor altered switching specificity (<ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20082311/DC1">Fig. S11</ext-link>). These data indicate that Ikaros does not suppress H3 acetylation and germline transcription by recruiting the NuRD and Sin3 HDAC complexes to the <italic>Igh</italic> locus.</p><p>Our results indicate that Ikaros may directly regulate germline transcription through the HS1,2 region of the <italic>Igh</italic> 3&#x02032; enhancer. Ikaros associates with HS1,2 in all conditions tested, and Ikaros proteins bind directly to a sequence in this region in vitro. In contrast, despite the association of Ikaros with the I&#x003b3;1, I&#x003b3;2b, and I&#x003b3;2a regions by ChIP, we were unable to identify sequences in these regions that could be strongly and directly bound by Ikaros. Although we cannot rule out binding to noncanonical sites, these data suggest that Ikaros binds directly to HS1,2 and interacts indirectly with I&#x003b3;1, I&#x003b3;2b, and I&#x003b3;2a. Our 3C data, as well as those from Wuerffel et al. (<xref ref-type="bibr" rid="bib16">16</xref>), support this interpretation, as HS1,2 interacts with fragments containing the &#x003b3;3, &#x003b3;1, &#x003b3;2b, and &#x003b3;2a I promoters/exons. Interestingly, HS1,2&#x02013;&#x003b3;1 interactions increase when this gene is transcribed (e.g., LPS + IL-4; <xref ref-type="fig" rid="fig4">Figs. 4</xref> and <xref ref-type="fig" rid="fig6">6</xref>) (<xref ref-type="bibr" rid="bib16">16</xref>), which correlates with the appearance of an Ikaros binding peak by ChIP. Similarly, Ikaros associates with I&#x003b3;2a only when cells are stimulated with LPS + IFN-&#x003b3;, which induces both &#x003b3;2a GLTs and increased HS1,2-I&#x003b3;2a interactions. Thus, we propose that Ikaros interacts indirectly with and regulates C<sub>H</sub> gene promoters through HS1,2.</p><p>The idea that Ikaros mediates repression through the HS1,2 regulatory region of the 3&#x02032; enhancer is bolstered by the observation that 3&#x02032; enhancer disruption most drastically affects transcription of and CSR to &#x003b3;3, &#x003b3;2b, and &#x003b3;2a, the C<sub>H</sub> genes most strongly affected by Ikaros deficiency (<xref ref-type="bibr" rid="bib14">14</xref>, <xref ref-type="bibr" rid="bib15">15</xref>). One issue with this model is that HS1,2 deletion does not affect CSR (<xref ref-type="bibr" rid="bib14">14</xref>), suggesting that HS1,2 may be not be functionally important for CSR and/or that it functions independently of Ikaros. This explanation, however, is probably too simplistic. In another complex locus, the &#x003b2;-globin locus, deletions of individual regulatory elements result in little to no phenotype, whereas combined deletions can drastically inhibit globin gene expression, indicating that the loss of individual elements can be compensated for by redundant functions in other regions (<xref ref-type="bibr" rid="bib49">49</xref>). Thus, compensation by other 3&#x02032; enhancer elements, which have many similar transcription factor motifs (<xref ref-type="bibr" rid="bib50">50</xref>), could explain the lack of CSR phenotype in HS1,2<sup>&#x02212;/&#x02212;</sup> cells. In addition, HS1,2 can strongly synergize with other HS fragments to activate transcription (<xref ref-type="bibr" rid="bib51">51</xref>), and the core region HS1,2 is highly conserved between mouse, rat, rabbit, and human (<xref ref-type="bibr" rid="bib52">52</xref>), indicating that HS1,2 is likely to play important roles in CSR.</p><p>How then, can HS1,2<sup>&#x02212;/&#x02212;</sup> and Ik<sup>L/L</sup> B cell CSR phenotypes be reconciled? An obvious possibility is that Ikaros could repress germline transcription and histone acetylation by antagonizing positive regulatory functions at this element. In this case, HS1,2 deletion would abolish both negative regulation by Ikaros and positive regulation by unknown factors, resulting in a neutral phenotype. In contrast, Ikaros deficiency would allow increased activity by positively acting factors, resulting in a significant phenotype. Interestingly, Ikaros has been shown to compete with positive regulators to modulate the transcription of target genes in other settings (<xref ref-type="bibr" rid="bib22">22</xref>, <xref ref-type="bibr" rid="bib53">53</xref>, <xref ref-type="bibr" rid="bib54">54</xref>). In this respect, our EMSA assay indicates that multiple factors can bind at or near the HS1,2&#x02013;Ikaros binding site (<xref ref-type="fig" rid="fig8">Fig. 8 F</xref>). Thus, it will be important to determine if Ikaros competes with other factors for binding to the HS1,2 regulatory element to fine tune germline transcription.</p><p>Finally, the efficiency of CSR is controlled by several mechanisms, including cell proliferation, AID expression, subcellular localization and posttranslational modifications, DSB formation, DNA repair, S region synapsis, and end joining (<xref ref-type="bibr" rid="bib1">1</xref>). Our results suggest that S region transcription rates in WT cells also limit switching efficiency. This concept is supported by (a) the low rates of CSR compared with switching competency in WT cells (&#x0223c;30% of cells switched after 4 d with LPS, whereas 70% were <italic>aicda</italic><sup>+</sup>GLT<sup>+</sup> after 48 h; <xref ref-type="fig" rid="fig3">Fig. 3</xref>, <xref ref-type="fig" rid="fig9">Fig. 9A</xref>, and Table S1), (b) the similar levels of CSR-competent cells in Ik<sup>L/L</sup> and WT cultures (67% of Ik<sup>L/L</sup> cells were <italic>aicda</italic><sup>+</sup>GLT<sup>+</sup> after 48 h; <xref ref-type="fig" rid="fig9">Fig. 9 A</xref> and Table S1), and (c) the direct correlation between increased per cell GLT levels, AID accessibility, and switching frequency in Ik<sup>L/L</sup> cells (&#x0223c;50% switched after 4 d; <xref ref-type="fig" rid="fig5">Fig. 5 B</xref>, <xref ref-type="fig" rid="fig9">Fig. 9 D</xref>, and Fig. S5 B). Why it would be advantageous to limit S region transcription rates and CSR efficiency under normal conditions is not clear. This mechanism could result in more flexible humoral immune responses in vivo, as slowing the rate of CSR may prevent B cells from switching en masse soon after activation, thus allowing isotype selection to be modified over time. In addition, reduced S region transcription, and therefore DSB formation, would decrease the probability of unrepaired DSBs, which can to lead to oncogenic translocations (<xref ref-type="bibr" rid="bib55">55</xref>).</p><p>In summary, our results reveal transcriptional competition between constant region genes as a central and general mechanism for isotype specification during CSR. We have shown that Ikaros is a master regulator of this competition.</p></sec><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><sec><title/><sec><title>Mice.</title><p>The Ik<sup>L/L</sup> mouse line was previously described (<xref ref-type="bibr" rid="bib21">21</xref>). Mice backcrossed &#x0003e;10 times onto the C57BL/6 genetic background were analyzed at 5&#x02013;9 wk of age. All animal work was performed under protocols approved by the Direction des Services V&#x000e9;t&#x000e9;rinaires du Bas-Rhin, France (authorization no. 67-343).</p></sec><sec><title>Cell culture.</title><p>Spleen cells were used for all experiments. B cells (B220<sup>+</sup>, IgM<sup>+</sup>CD43<sup>&#x02212;</sup>, or CD43<sup>&#x02212;</sup>IgG/A<sup>&#x02212;</sup> cells; &#x0003e;98% purity) were sorted on a FACSVantage SE option DIVA (BD) or enriched by depletion of CD43<sup>+</sup> cells with MACS beads (&#x0003e;90% purity), and CD4<sup>+</sup> T cells were isolated with anti-CD4 MACS beads (&#x0003e;90% purity; Miltenyi Biotech). Cells were labeled with 5 &#x000b5;g/ml CFSE (10 min at 37&#x000b0;C; Sigma-Aldrich) and were maintained at 1.2 &#x000d7; 10<sup>6</sup> cells/ml in complete medium (RPMI 1640, 10% FCS, 25 mM Hepes, 1 mM sodium pyruvate, 2 mM <sc>l</sc>-glutamine, 1&#x000d7; nonessential amino acids, 5 &#x000d7; 10<sup>&#x02212;5</sup> M 2-mercaptoethanol, and 1% antibiotics) with 25 &#x000b5;g/ml LPS (serotype 0111:B4 from <italic>Escherichia coli</italic>; Sigma-Aldrich), 5 ng/ml IL-4 (Sigma-Aldrich), 100 ng/ml IFN-&#x003b3; (PeproTech), 3 ng/ml TGF-&#x003b2; (R&#x00026;D Systems), 5 ng/ml IL-5 (BD), and 0.5 ng/ml PMA (Sigma-Aldrich).</p></sec><sec><title>Flow cytometry.</title><p>Reagents included anti-B220&#x02013;FITC (RA3-6B2), anti&#x02013;mouse IgG<sub>2b</sub>&#x02013;biotin (RMG2b-1; BioLegend), anti&#x02013;mouse IgA&#x02013;PE (SouthernBiotech), F(ab&#x02032;)<sub>2</sub> goat anti&#x02013;mouse IgM&#x02013;Cy5 and streptavidin-Cy5 or -PE (Jackson ImmunoResearch Laboratories), anti&#x02013;mouse IgG<sub>3</sub>&#x02013;biotin (R40-82), anti&#x02013;mouse IgG<sub>1</sub>&#x02013;biotin (A85-1), anti&#x02013;mouse IgG<sub>2a</sub><sup>b</sup>&#x02013;biotin (Igh-b; 5.7) and anti-CD43&#x02013;PE (BD), goat anti&#x02013;mouse IgG (H+L)&#x02013;biotin (Invitrogen), anti-NGFR&#x02013;Cy5 (8737; provided by W. Pear, University of Pennsylvania, Philadelphia, PA), and 7-aminoactinomycin D (Sigma-Aldrich). Cells were analyzed with a FACSCalibur (BD) and FlowJo software (Tree Star, Inc.).</p></sec><sec><title>RT-qPCR.</title><p>RNA was isolated with RNeasy kits (QIAGEN). 350 ng RNA was reverse transcribed in 20 &#x000b5;l (50 mM Tris-HCl [pH 8.3], 75 mM KCl, 3 mM MgCl<sub>2</sub>, 10 mM dithiothreitol, 500 &#x000b5;M dNTP, 10 U recombinant RNasin ribonuclease inhibitor [Promega], 0.5 &#x000b5;M oligo d(T) [New England Biolabs, Inc.], and 40 U SuperScript II RT [Invitrogen]). SYBR Green JumpStart Taq ReadyMix (Sigma-Aldrich) was used for all qPCRs. Approximately 3 ng of cDNA was run (in triplicate) on a LightCycler 480 (96-well plate format) and analyzed with LightCycler 480 basic software (Roche). Transcript quantities for each gene were calculated relative to standard curves and normalized to <italic>Ig&#x003b2;</italic> transcripts. Gene of interest/Ig&#x003b2; ratios for each condition were averaged across experiments and normalized to the indicated WT condition, to give relative expression versus WT or versus unstimulated WT, as noted. <ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20082311/DC1">Table S2</ext-link> lists oligonucleotides for all experiments.</p></sec><sec><title>SC-RT-PCR.</title><p>Two rounds of PCR were performed with fully nested primers, as previously described (<xref ref-type="bibr" rid="bib54">54</xref>). Only <italic>actb</italic><sup>+</sup> wells were analyzed (&#x0003e;90%).</p></sec><sec><title>Retrovirus production and transduction.</title><p>MigR1-NGFR (provided by W. Pear) is an murine stem cell virus&#x02013;based retrovirus (<xref ref-type="bibr" rid="bib56">56</xref>). Ik1 cDNA was amplified from mouse spleen cDNA by PCR (bp 271&#x02013;1,818; available from GenBank/EMBL/DDBJ under accession no. <ext-link ext-link-type="gen" xlink:href="NM_001025597">NM_001025597</ext-link>). Ik1* cDNA was obtained by site-directed mutagenesis to delete exon 2&#x02013;derived Ik1 sequences (bp 310&#x02013;430). Ik6 cDNA was obtained by fusing PCR fragments for exons 1 and 2 (bp 271&#x02013;429) and exon 7 (bp 1,117&#x02013;1,818) of Ik1. cDNAs were cloned into the MigR1-NGFR vector and were designated Ik1-NGFR, Ik1*-NGFR, and Ik6-NGFR. pQsupR-Mi2 (Mi-2&#x003b2; shRNA; provided by S. Smale, University of California, Los Angeles, Los Angeles, CA) and pQsupR (mock) vectors were previously described (<xref ref-type="bibr" rid="bib57">57</xref>). Vectors were transfected into Eco-Phoenix packaging cells (provided by G. Nolan, Stanford University, Stanford, CA) to produce high-titer retroviral supernatants. 3.5 &#x000d7; 10<sup>5</sup> CFSE-stained cells (1.2 &#x000d7; 10<sup>6</sup> cells/ml) were cultured in LPS for 24 h, transduced with retroviral supernatant (25% total vol; 4 &#x000b5;g/ml polybrene; 25 &#x000b5;g/ml LPS), and centrifuged for 90 min at 2,600 rpm. Medium was replaced after 12 h and cells were analyzed 60 h later.</p></sec><sec><title>ChIP.</title><p>The ChIP protocol was adapted from Wang et al. (<xref ref-type="bibr" rid="bib18">18</xref>) and Millipore (<ext-link ext-link-type="uri" xlink:href="http://www.millipore.com/techpublications/tech1/mcproto407">http://www.millipore.com/techpublications/tech1/mcproto407</ext-link>). In brief, 1.8 &#x000d7; 10<sup>7</sup> B cells were cross-linked at 37&#x000b0;C for 10 min in 5 ml PBS/0.5% BSA/1% ultra-pure formaldehyde (Electron Microscopy Sciences). After quenching with 0.125 M glycine and a cold PBS wash (with 1&#x000d7; protease inhibitor cocktail [PIC]; Roche), cells were lysed in 5 ml of Triton X lysis buffer for 10 min on ice (1% Triton X-100, 50 mM MgCl<sub>2</sub>, 100 mM Tris-HCl [pH 7.1], 11% sucrose, 1&#x000d7; PIC). Nuclei were pelleted at 2,000 rpm for 10 min (4&#x000b0;C) and were lysed in 500 &#x000b5;l of SDS lysis buffer for 10 min on ice (1% SDS, 50 mM Tris-HCl, 10 mM EDTA, 1&#x000d7; PIC). Chromatin was sonicated to 500-1,000 bp using a Bioruptor 200 (Diagenode), and sonication efficiency was checked. After 2&#x000d7; dilution in ChIP buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl [pH 8.1], 167 mM NaCl), chromatin was precleared by rotating for 2 h at 4&#x000b0;C with 80 &#x000b5;l 50% protein A slurry (0.2 mg/ml sheared salmon sperm DNA, 0.5 mg/ml BSA, 50% protein A; GE Healthcare). 1.3 &#x000d7; 10<sup>6</sup> cell equivalents were saved as input. 3.9 &#x000d7; 10<sup>6</sup> cell equivalents were incubated overnight with 2 &#x000b5;g anti-AcH3 (Millipore), 2 &#x000b5;g anti-AcH4 (Millipore), 2.5 &#x000b5;g anti-Ikaros (rabbit anti&#x02013;mouse produced in house), anti&#x02013;Mi-2&#x003b2; (5 &#x000b5;l of rabbit serum; gifts from P. Wade [National Institute of Environmental Health Sciences, Research Triangle Park, NC] and S. Smale), 5 &#x000b5;g anti-Sin3a (Santa Cruz Biotechnology, Inc.), 5 &#x000b5;g anti-HDAC1 (Abcam), 5 &#x000b5;g anti-HDAC2 (Abcam), and control antibodies (Bethyl Laboratories). ChIPs were recovered with 65 &#x000b5;l 50% protein A slurry for 5 h and processed according to the Millipore protocol. ChIP and input DNA was dissolved in 140 &#x000b5;l TE buffer (10 mM Tris-HCl, 1 mM EDTA [ph 8]), and inputs were diluted 10 times. 2-&#x000b5;l aliquots were analyzed (in duplicate) by qPCR. Calculations were as follows: percentage input (%I) = 100 &#x000d7; ([antibody bound] &#x02212; [IgG bound])/(input*10); and histone acetylation index = (%I<italic><sup>Igh</sup></italic><sup>sequence</sup>)/(%I<italic><sup>Hprt</sup></italic><sup>promoter</sup>). For DC-ChIP, cells were first fixed with disuccinimidyl glutarate (<xref ref-type="bibr" rid="bib58">58</xref>).</p></sec><sec><title>3C.</title><p>3C was performed as previously described (<xref ref-type="bibr" rid="bib59">59</xref>) with some modifications. In brief, 11 &#x000d7; 10<sup>6</sup> cells were fixed for 10 min in 10 ml 1&#x000d7; PBS/0.5% BSA/1.5% formaldehyde (Electron Microscopy Sciences) at room temperature with tumbling (10 rpm). Fixation was quenched with 0.125 M glycine. Cells were washed one time in cold PBS/1&#x000d7; PIC and lysed for 10 min on ice in 1 ml of lysis buffer (10 mM Tris [pH 8], 10 mM NaCl, 0.2% NP-40, 1&#x000d7; PIC). After centrifugation, cells were resuspended in 537 &#x000b5;l of digestion buffer (60 &#x000b5;l of 10&#x000d7; buffer R [Fermentas], 1&#x000d7; PIC). SDS was added to 0.3% and samples were rotated for 1 h at 37&#x000b0;C (99 rpm). Triton X was added to 1.8% to sequester SDS, bringing the total volume to 600 &#x000b5;l. Samples were rotated (99 rpm) for 1 h at 37&#x000b0;C before overnight digestion with 500 U HindIII (50 rpm; New England Biolabs, Inc.). HindIII was inactivated by adding SDS to 1.75% and incubating for 20 min at 65&#x000b0;C. 10<sup>6</sup> cell equivalents were removed, de&#x02013;cross-linked, and analyzed by qPCR to monitor digestion efficiency (routinely 80&#x02013;90%; Fig. S9 A). 10<sup>7</sup> cell equivalents were diluted to 8 ml in 1&#x000d7; ligation buffer (New England Biolabs), 1% Triton X, and 1&#x000d7; PIC, and SDS was sequestered by rocking for 1 h at 37&#x000b0;C. 4,000 NEB U of ligase (New England Biolabs, Inc.) were added and samples were rocked for 10 min at 4&#x000b0;C before incubation for 6 h at 16&#x000b0;C, followed by 30 min at room temperature. Samples were de&#x02013;cross-linked overnight at 65&#x000b0;C with 300 &#x000b5;g protease K and were retreated with 300 &#x000b5;g protease K for 1 h at 45&#x000b0;C. DNA was extracted using ultra-pure phenol/chloroform/isoamyl alcohol (25:24:1; Invitrogen), washed two times with chloroform, ethanol precipitated with 2.5 M ammonium acetate, and washed four times with 75% ethanol. After suspension in TE, relative DNA concentrations were calculated by qPCR (ChIP primers &#x0201c;HS4 &#x02212;0.5 kb&#x0201d;).</p><p>Ligation products were analyzed by qPCR in duplicate or triplicate using &#x0223c;200 ng DNA. Absolute quantities were calculated using a template consisting of equimolar ratios of all possible ligation products. The template was constructed as previously described (<xref ref-type="bibr" rid="bib60">60</xref>) with PCR fragments from the <italic>Igh</italic> and <italic>Gapd</italic> loci and diluted in genomic DNA. qPCR specificity was confirmed with negative controls (without fixation, digestion, or ligation), melting point analysis, digestion of PCR products with HindIII, and migration of PCR and digestion products on 2% agarose gels (Fig. S9 B). Relative cross-linking frequency was calculated as follows: cross-linking frequency = ([HS1,2 &#x02212; fragment X]/[HS4 &#x02212;0.5 kb loading control])/([<italic>Gapd</italic> 3&#x02032; &#x02212; <italic>Gapd</italic> 5&#x02032;]/[HS4 &#x02212;0.5 kb]).</p></sec><sec><title>EMSA.</title><p>Nuclear extracts (NEs) and EMSAs were prepared as previously described (<xref ref-type="bibr" rid="bib61">61</xref>). 2.5 &#x000b5;g NE from Cos cells transfected with mock cDNA or cDNA coding for Ik1 proteins or 4 &#x000b5;g NE from CSR-induced B cells was used.</p></sec><sec><title>Online supplemental material.</title><p>Table S1 summarizes raw data from SC-RT-PCR experiments. Table S2 lists oligonucleotides. Fig. S1 shows statistical analysis of WT and Ik<sup>L/L</sup> CSR frequencies after LPS, LPS + IL-4, LPS + IFN-&#x003b3;, and LPS + IL-5 + TGF-&#x003b2; stimulation. Fig. S2 quantifies Ig isotype production by WT and Ik<sup>L/L</sup> B cells using ELISA. Fig. S3 analyzes WT and Ik<sup>L/L</sup> CSR frequency as a function of proliferation. Fig. S4 examines CSR in whole and bona fide unswitched WT and Ik<sup>L/L</sup> B cells. Fig. S5 shows the effect of retroviral expression of dominant-negative Ikaros on CSR in WT cells, and full-length and exon 2&#x02013;deleted Ikaros isoforms on CSR in Ik<sup>L/L</sup> B cells. Fig. S6 shows RT-qPCR analysis of <italic>aicda</italic> expression in stimulated WT and Ik<sup>L/L</sup> cells. Fig. S7 shows SC-RT-PCR analysis of <italic>aicda</italic>, &#x003b3;3 GLT, and &#x003b3;2b GLT expression in freshly isolated IgM<sup>+</sup>CD43<sup>&#x02212;</sup> B cells and CD4<sup>+</sup>CD3<sup>+</sup> T cells. Fig. S8 shows RT-qPCR analysis of &#x003bc;, &#x003b3;3, &#x003b3;2b, and &#x003b3;2a GLT expression in WT and Ik<sup>L/L</sup> B cells after 48 h with LPS and one or three divisions. Fig. S9 shows digestion efficiency and PCR specificity controls for 3C experiments. Fig. S10 shows ChIP-qPCR and DC-ChIP-qPCR for Mi-2&#x003b2;, Sin3a, HDAC1, and HDAC2 at the <italic>Igh</italic> locus in WT and Ik<sup>L/L</sup> cells. Fig. S11 shows the effect of Mi-2&#x003b2; shRNA knockdown on CSR in WT B cells. Online supplemental material is available at <ext-link ext-link-type="uri" xlink:href="http://www.jem.org/cgi/content/full/jem.20082311/DC1">http://www.jem.org/cgi/content/full/jem.20082311/DC1</ext-link>.</p></sec></sec></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="PMC_1" content-type="local-data"><caption><title>[Supplemental Material Index]</title></caption><media mimetype="text" mime-subtype="html" xlink:href="jem.20082311_index.html"/><media xlink:role="associated-file" mimetype="application" mime-subtype="pdf" xlink:href="jem.20082311_1.pdf"/></supplementary-material></sec></body><back><ack><p>We thank G. Nolan; W. Pear; S. Smale and P. Wade for critical reagents; J. Barths, C. Ebel, and P. Marchal for FACS; P. Marchal for technical assistance; and M. Gendron for animal husbandry.</p><p>M. Sellars received a predoctoral fellowship from La Fondation pour la Recherche M&#x000e9;dicale. B. Reina-San-Martin is an AVENIR&#x02013;Institut National de la Sant&#x000e9; et de la Recherche M&#x000e9;dicale (INSERM) young investigator. The work was supported by INSERM, the Centre National pour la Recherche Scientifique, and the H&#x000f4;pital Universitaire de Strasbourg, as well as by a grant from L&#x02019;Agence Nationale de la Recherche (to B. Reina-San-Martin, S. Chan, and P. Kastner).</p><p>The authors have no conflicting financial interests.</p></ack><ref-list><ref id="bib1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stavnezer</surname><given-names>J.</given-names></name><name><surname>Guikema</surname><given-names>J.E.</given-names></name><name><surname>Schrader</surname><given-names>C.E.</given-names></name></person-group><year>2008</year><article-title>Mechanism and regulation of class switch recombination</article-title>.<source>Annu. Rev. Immunol.</source><volume>26</volume>:<fpage>261</fpage>&#x02013;<lpage>292</lpage><pub-id pub-id-type="pmid">18370922</pub-id></mixed-citation></ref><ref id="bib2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imai</surname><given-names>K.</given-names></name><name><surname>Catalan</surname><given-names>N.</given-names></name><name><surname>Plebani</surname><given-names>A.</given-names></name><name><surname>Marodi</surname><given-names>L.</given-names></name><name><surname>Sanal</surname><given-names>O.</given-names></name><name><surname>Kumaki</surname><given-names>S.</given-names></name><name><surname>Nagendran</surname><given-names>V.</given-names></name><name><surname>Wood</surname><given-names>P.</given-names></name><name><surname>Glastre</surname><given-names>C.</given-names></name><name><surname>Sarrot-Reynauld</surname><given-names>F.</given-names></name><etal/></person-group><year>2003</year><article-title>Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination</article-title>.<source>J. Clin. Invest.</source><volume>112</volume>:<fpage>136</fpage>&#x02013;<lpage>142</lpage><pub-id pub-id-type="pmid">12840068</pub-id></mixed-citation></ref><ref id="bib3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muramatsu</surname><given-names>M.</given-names></name><name><surname>Kinoshita</surname><given-names>K.</given-names></name><name><surname>Fagarasan</surname><given-names>S.</given-names></name><name><surname>Yamada</surname><given-names>S.</given-names></name><name><surname>Shinkai</surname><given-names>Y.</given-names></name><name><surname>Honjo</surname><given-names>T.</given-names></name></person-group><year>2000</year><article-title>Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme</article-title>.<source>Cell.</source><volume>102</volume>:<fpage>553</fpage>&#x02013;<lpage>563</lpage><pub-id pub-id-type="pmid">11007474</pub-id></mixed-citation></ref><ref id="bib4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Revy</surname><given-names>P.</given-names></name><name><surname>Muto</surname><given-names>T.</given-names></name><name><surname>Levy</surname><given-names>Y.</given-names></name><name><surname>Geissmann</surname><given-names>F.</given-names></name><name><surname>Plebani</surname><given-names>A.</given-names></name><name><surname>Sanal</surname><given-names>O.</given-names></name><name><surname>Catalan</surname><given-names>N.</given-names></name><name><surname>Forveille</surname><given-names>M.</given-names></name><name><surname>Dufourcq-Labelouse</surname><given-names>R.</given-names></name><name><surname>Gennery</surname><given-names>A.</given-names></name><etal/></person-group><year>2000</year><article-title>Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2)</article-title>.<source>Cell.</source><volume>102</volume>:<fpage>565</fpage>&#x02013;<lpage>575</lpage><pub-id pub-id-type="pmid">11007475</pub-id></mixed-citation></ref><ref id="bib5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen-Mahrt</surname><given-names>S.K.</given-names></name><name><surname>Harris</surname><given-names>R.S.</given-names></name><name><surname>Neuberger</surname><given-names>M.S.</given-names></name></person-group><year>2002</year><article-title>AID mutates <italic>E. coli</italic> suggesting a DNA deamination mechanism for antibody diversification</article-title>.<source>Nature.</source><volume>418</volume>:<fpage>99</fpage>&#x02013;<lpage>103</lpage><pub-id pub-id-type="pmid">12097915</pub-id></mixed-citation></ref><ref id="bib6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rada</surname><given-names>C.</given-names></name><name><surname>Williams</surname><given-names>G.T.</given-names></name><name><surname>Nilsen</surname><given-names>H.</given-names></name><name><surname>Barnes</surname><given-names>D.E.</given-names></name><name><surname>Lindahl</surname><given-names>T.</given-names></name><name><surname>Neuberger</surname><given-names>M.S.</given-names></name></person-group><year>2002</year><article-title>Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice</article-title>.<source>Curr. Biol.</source><volume>12</volume>:<fpage>1748</fpage>&#x02013;<lpage>1755</lpage><pub-id pub-id-type="pmid">12401169</pub-id></mixed-citation></ref><ref id="bib7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muramatsu</surname><given-names>M.</given-names></name><name><surname>Nagaoka</surname><given-names>H.</given-names></name><name><surname>Shinkura</surname><given-names>R.</given-names></name><name><surname>Begum</surname><given-names>N.A.</given-names></name><name><surname>Honjo</surname><given-names>T.</given-names></name></person-group><year>2007</year><article-title>Discovery of activation-induced cytidine deaminase, the engraver of antibody memory</article-title>.<source>Adv. Immunol.</source><volume>94</volume>:<fpage>1</fpage>&#x02013;<lpage>36</lpage><pub-id pub-id-type="pmid">17560270</pub-id></mixed-citation></ref><ref id="bib8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramiro</surname><given-names>A.</given-names></name><name><surname>San-Martin</surname><given-names>B.R.</given-names></name><name><surname>McBride</surname><given-names>K.</given-names></name><name><surname>Jankovic</surname><given-names>M.</given-names></name><name><surname>Barreto</surname><given-names>V.</given-names></name><name><surname>Nussenzweig</surname><given-names>A.</given-names></name><name><surname>Nussenzweig</surname><given-names>M.C.</given-names></name></person-group><year>2007</year><article-title>The role of activation-induced deaminase in antibody diversification and chromosome translocations</article-title>.<source>Adv. Immunol.</source><volume>94</volume>:<fpage>75</fpage>&#x02013;<lpage>107</lpage><pub-id pub-id-type="pmid">17560272</pub-id></mixed-citation></ref><ref id="bib9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaudhuri</surname><given-names>J.</given-names></name><name><surname>Alt</surname><given-names>F.W.</given-names></name></person-group><year>2004</year><article-title>Class-switch recombination: interplay of transcription, DNA deamination and DNA repair</article-title>.<source>Nat. Rev. Immunol.</source><volume>4</volume>:<fpage>541</fpage>&#x02013;<lpage>552</lpage><pub-id pub-id-type="pmid">15229473</pub-id></mixed-citation></ref><ref id="bib10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>S.</given-names></name><name><surname>Rajewsky</surname><given-names>K.</given-names></name><name><surname>Radbruch</surname><given-names>A.</given-names></name></person-group><year>1993</year><article-title>Shutdown of class switch recombination by deletion of a switch region control element</article-title>.<source>Science.</source><volume>259</volume>:<fpage>984</fpage>&#x02013;<lpage>987</lpage><pub-id pub-id-type="pmid">8438159</pub-id></mixed-citation></ref><ref id="bib11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Bottaro</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Stewart</surname><given-names>V.</given-names></name><name><surname>Alt</surname><given-names>F.W.</given-names></name></person-group><year>1993</year><article-title>A selective defect in IgG2b switching as a result of targeted mutation of the I gamma 2b promoter and exon</article-title>.<source>EMBO J.</source><volume>12</volume>:<fpage>3529</fpage>&#x02013;<lpage>3537</lpage><pub-id pub-id-type="pmid">8253079</pub-id></mixed-citation></ref><ref id="bib12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seidl</surname><given-names>K.J.</given-names></name><name><surname>Bottaro</surname><given-names>A.</given-names></name><name><surname>Vo</surname><given-names>A.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Davidson</surname><given-names>L.</given-names></name><name><surname>Alt</surname><given-names>F.W.</given-names></name></person-group><year>1998</year><article-title>An expressed neo(r) cassette provides required functions of the 1gamma2b exon for class switching</article-title>.<source>Int. Immunol.</source><volume>10</volume>:<fpage>1683</fpage>&#x02013;<lpage>1692</lpage><pub-id pub-id-type="pmid">9846697</pub-id></mixed-citation></ref><ref id="bib13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>G.</given-names></name><name><surname>Harriman</surname><given-names>G.R.</given-names></name><name><surname>Stavnezer</surname><given-names>J.</given-names></name></person-group><year>1999</year><article-title>Ialpha exon-replacement mice synthesize a spliced HPRT-C(alpha) transcript which may explain their ability to switch to IgA. Inhibition of switching to IgG in these mice</article-title>.<source>Int. Immunol.</source><volume>11</volume>:<fpage>37</fpage>&#x02013;<lpage>46</lpage><pub-id pub-id-type="pmid">10050672</pub-id></mixed-citation></ref><ref id="bib14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manis</surname><given-names>J.P.</given-names></name><name><surname>van der Stoep</surname><given-names>N.</given-names></name><name><surname>Tian</surname><given-names>M.</given-names></name><name><surname>Ferrini</surname><given-names>R.</given-names></name><name><surname>Davidson</surname><given-names>L.</given-names></name><name><surname>Bottaro</surname><given-names>A.</given-names></name><name><surname>Alt</surname><given-names>F.W.</given-names></name></person-group><year>1998</year><article-title>Class switching in B cells lacking 3&#x02032; immunoglobulin heavy chain enhancers</article-title>.<source>J. Exp. Med.</source><volume>188</volume>:<fpage>1421</fpage>&#x02013;<lpage>1431</lpage><pub-id pub-id-type="pmid">9782119</pub-id></mixed-citation></ref><ref id="bib15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinaud</surname><given-names>E.</given-names></name><name><surname>Khamlichi</surname><given-names>A.A.</given-names></name><name><surname>Le Morvan</surname><given-names>C.</given-names></name><name><surname>Drouet</surname><given-names>M.</given-names></name><name><surname>Nalesso</surname><given-names>V.</given-names></name><name><surname>Le Bert</surname><given-names>M.</given-names></name><name><surname>Cogne</surname><given-names>M.</given-names></name></person-group><year>2001</year><article-title>Localization of the 3&#x02032; IgH locus elements that effect long-distance regulation of class switch recombination</article-title>.<source>Immunity.</source><volume>15</volume>:<fpage>187</fpage>&#x02013;<lpage>199</lpage><pub-id pub-id-type="pmid">11520455</pub-id></mixed-citation></ref><ref id="bib16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wuerffel</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Grigera</surname><given-names>F.</given-names></name><name><surname>Manis</surname><given-names>J.</given-names></name><name><surname>Selsing</surname><given-names>E.</given-names></name><name><surname>Perlot</surname><given-names>T.</given-names></name><name><surname>Alt</surname><given-names>F.W.</given-names></name><name><surname>Cogne</surname><given-names>M.</given-names></name><name><surname>Pinaud</surname><given-names>E.</given-names></name><name><surname>Kenter</surname><given-names>A.L.</given-names></name></person-group><year>2007</year><article-title>S-S synapsis during class switch recombination is promoted by distantly located transcriptional elements and activation-induced deaminase</article-title>.<source>Immunity.</source><volume>27</volume>:<fpage>711</fpage>&#x02013;<lpage>722</lpage><pub-id pub-id-type="pmid">17980632</pub-id></mixed-citation></ref><ref id="bib17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nambu</surname><given-names>Y.</given-names></name><name><surname>Sugai</surname><given-names>M.</given-names></name><name><surname>Gonda</surname><given-names>H.</given-names></name><name><surname>Lee</surname><given-names>C.G.</given-names></name><name><surname>Katakai</surname><given-names>T.</given-names></name><name><surname>Agata</surname><given-names>Y.</given-names></name><name><surname>Yokota</surname><given-names>Y.</given-names></name><name><surname>Shimizu</surname><given-names>A.</given-names></name></person-group><year>2003</year><article-title>Transcription-coupled events associating with immunoglobulin switch region chromatin</article-title>.<source>Science.</source><volume>302</volume>:<fpage>2137</fpage>&#x02013;<lpage>2140</lpage><pub-id pub-id-type="pmid">14684824</pub-id></mixed-citation></ref><ref id="bib18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Whang</surname><given-names>N.</given-names></name><name><surname>Wuerffel</surname><given-names>R.</given-names></name><name><surname>Kenter</surname><given-names>A.L.</given-names></name></person-group><year>2006</year><article-title>AID-dependent histone acetylation is detected in immunoglobulin S regions</article-title>.<source>J. Exp. Med.</source><volume>203</volume>:<fpage>215</fpage>&#x02013;<lpage>226</lpage><pub-id pub-id-type="pmid">16418396</pub-id></mixed-citation></ref><ref id="bib19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.H.</given-names></name><name><surname>Nichogiannopoulou</surname><given-names>A.</given-names></name><name><surname>Wu</surname><given-names>L.</given-names></name><name><surname>Sun</surname><given-names>L.</given-names></name><name><surname>Sharpe</surname><given-names>A.H.</given-names></name><name><surname>Bigby</surname><given-names>M.</given-names></name><name><surname>Georgopoulos</surname><given-names>K.</given-names></name></person-group><year>1996</year><article-title>Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation</article-title>.<source>Immunity.</source><volume>5</volume>:<fpage>537</fpage>&#x02013;<lpage>549</lpage><pub-id pub-id-type="pmid">8986714</pub-id></mixed-citation></ref><ref id="bib20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynaud</surname><given-names>D.</given-names></name><name><surname>Demarco</surname><given-names>I.A.</given-names></name><name><surname>Reddy</surname><given-names>K.L.</given-names></name><name><surname>Schjerven</surname><given-names>H.</given-names></name><name><surname>Bertolino</surname><given-names>E.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Smale</surname><given-names>S.T.</given-names></name><name><surname>Winandy</surname><given-names>S.</given-names></name><name><surname>Singh</surname><given-names>H.</given-names></name></person-group><year>2008</year><article-title>Regulation of B cell fate commitment and immunoglobulin heavy-chain gene rearrangements by Ikaros</article-title>.<source>Nat. Immunol.</source><volume>9</volume>:<fpage>927</fpage>&#x02013;<lpage>936</lpage><pub-id pub-id-type="pmid">18568028</pub-id></mixed-citation></ref><ref id="bib21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirstetter</surname><given-names>P.</given-names></name><name><surname>Thomas</surname><given-names>M.</given-names></name><name><surname>Dierich</surname><given-names>A.</given-names></name><name><surname>Kastner</surname><given-names>P.</given-names></name><name><surname>Chan</surname><given-names>S.</given-names></name></person-group><year>2002</year><article-title>Ikaros is critical for B cell differentiation and function</article-title>.<source>Eur. J. Immunol.</source><volume>32</volume>:<fpage>720</fpage>&#x02013;<lpage>730</lpage><pub-id pub-id-type="pmid">11870616</pub-id></mixed-citation></ref><ref id="bib22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>E.C.</given-names></name><name><surname>Cobb</surname><given-names>B.S.</given-names></name><name><surname>Sabbattini</surname><given-names>P.</given-names></name><name><surname>Meixlsperger</surname><given-names>S.</given-names></name><name><surname>Parelho</surname><given-names>V.</given-names></name><name><surname>Liberg</surname><given-names>D.</given-names></name><name><surname>Taylor</surname><given-names>B.</given-names></name><name><surname>Dillon</surname><given-names>N.</given-names></name><name><surname>Georgopoulos</surname><given-names>K.</given-names></name><name><surname>Jumaa</surname><given-names>H.</given-names></name><etal/></person-group><year>2007</year><article-title>Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuits</article-title>.<source>Immunity.</source><volume>26</volume>:<fpage>335</fpage>&#x02013;<lpage>344</lpage><pub-id pub-id-type="pmid">17363301</pub-id></mixed-citation></ref><ref id="bib23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Widlak</surname><given-names>P.</given-names></name><name><surname>Zou</surname><given-names>Y.</given-names></name><name><surname>Xiao</surname><given-names>F.</given-names></name><name><surname>Oh</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Chang</surname><given-names>M.Y.</given-names></name><name><surname>Shay</surname><given-names>J.W.</given-names></name><name><surname>Garrard</surname><given-names>W.T.</given-names></name></person-group><year>2006</year><article-title>A recombination silencer that specifies heterochromatin positioning and ikaros association in the immunoglobulin kappa locus</article-title>.<source>Immunity.</source><volume>24</volume>:<fpage>405</fpage>&#x02013;<lpage>415</lpage><pub-id pub-id-type="pmid">16618599</pub-id></mixed-citation></ref><ref id="bib24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldmit</surname><given-names>M.</given-names></name><name><surname>Ji</surname><given-names>Y.</given-names></name><name><surname>Skok</surname><given-names>J.</given-names></name><name><surname>Roldan</surname><given-names>E.</given-names></name><name><surname>Jung</surname><given-names>S.</given-names></name><name><surname>Cedar</surname><given-names>H.</given-names></name><name><surname>Bergman</surname><given-names>Y.</given-names></name></person-group><year>2005</year><article-title>Epigenetic ontogeny of the Igk locus during B cell development</article-title>.<source>Nat. Immunol.</source><volume>6</volume>:<fpage>198</fpage>&#x02013;<lpage>203</lpage><pub-id pub-id-type="pmid">15619624</pub-id></mixed-citation></ref><ref id="bib25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S.C.</given-names></name><name><surname>Rothman</surname><given-names>P.B.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Chan</surname><given-names>C.</given-names></name><name><surname>Hirsh</surname><given-names>D.</given-names></name><name><surname>Alt</surname><given-names>F.W.</given-names></name></person-group><year>1994</year><article-title>Expression of I mu-C gamma hybrid germline transcripts subsequent to immunoglobulin heavy chain class switching</article-title>.<source>Int. Immunol.</source><volume>6</volume>:<fpage>491</fpage>&#x02013;<lpage>497</lpage><pub-id pub-id-type="pmid">8018590</pub-id></mixed-citation></ref><ref id="bib26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodgkin</surname><given-names>P.D.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name><name><surname>Lyons</surname><given-names>A.B.</given-names></name></person-group><year>1996</year><article-title>B cell differentiation and isotype switching is related to division cycle number</article-title>.<source>J. Exp. Med.</source><volume>184</volume>:<fpage>277</fpage>&#x02013;<lpage>281</lpage><pub-id pub-id-type="pmid">8691143</pub-id></mixed-citation></ref><ref id="bib27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wojcik</surname><given-names>H.</given-names></name><name><surname>Griffiths</surname><given-names>E.</given-names></name><name><surname>Staggs</surname><given-names>S.</given-names></name><name><surname>Hagman</surname><given-names>J.</given-names></name><name><surname>Winandy</surname><given-names>S.</given-names></name></person-group><year>2007</year><article-title>Expression of a non-DNA-binding Ikaros isoform exclusively in B cells leads to autoimmunity but not leukemogenesis</article-title>.<source>Eur. J. Immunol.</source><volume>37</volume>:<fpage>1022</fpage>&#x02013;<lpage>1032</lpage><pub-id pub-id-type="pmid">17357110</pub-id></mixed-citation></ref><ref id="bib28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>A.</given-names></name><name><surname>Georgopoulos</surname><given-names>K.</given-names></name></person-group><year>1996</year><article-title>Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development</article-title>.<source>EMBO J.</source><volume>15</volume>:<fpage>5358</fpage>&#x02013;<lpage>5369</lpage><pub-id pub-id-type="pmid">8895580</pub-id></mixed-citation></ref><ref id="bib29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takizawa</surname><given-names>M.</given-names></name><name><surname>Tolarova</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Dubois</surname><given-names>W.</given-names></name><name><surname>Lim</surname><given-names>S.</given-names></name><name><surname>Callen</surname><given-names>E.</given-names></name><name><surname>Franco</surname><given-names>S.</given-names></name><name><surname>Mosaico</surname><given-names>M.</given-names></name><name><surname>Feigenbaum</surname><given-names>L.</given-names></name><name><surname>Alt</surname><given-names>F.W.</given-names></name><etal/></person-group><year>2008</year><article-title>AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development</article-title>.<source>J. Exp. Med.</source><volume>205</volume>:<fpage>1949</fpage>&#x02013;<lpage>1957</lpage><pub-id pub-id-type="pmid">18678733</pub-id></mixed-citation></ref><ref id="bib30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorsett</surname><given-names>Y.</given-names></name><name><surname>McBride</surname><given-names>K.M.</given-names></name><name><surname>Jankovic</surname><given-names>M.</given-names></name><name><surname>Gazumyan</surname><given-names>A.</given-names></name><name><surname>Thai</surname><given-names>T.H.</given-names></name><name><surname>Robbiani</surname><given-names>D.F.</given-names></name><name><surname>Di Virgilio</surname><given-names>M.</given-names></name><name><surname>San-Martin</surname><given-names>B.R.</given-names></name><name><surname>Heidkamp</surname><given-names>G.</given-names></name><name><surname>Schwickert</surname><given-names>T.A.</given-names></name><etal/></person-group><year>2008</year><article-title>MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation</article-title>.<source>Immunity.</source><volume>28</volume>:<fpage>630</fpage>&#x02013;<lpage>638</lpage><pub-id pub-id-type="pmid">18455451</pub-id></mixed-citation></ref><ref id="bib31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teng</surname><given-names>G.</given-names></name><name><surname>Hakimpour</surname><given-names>P.</given-names></name><name><surname>Landgraf</surname><given-names>P.</given-names></name><name><surname>Rice</surname><given-names>A.</given-names></name><name><surname>Tuschl</surname><given-names>T.</given-names></name><name><surname>Casellas</surname><given-names>R.</given-names></name><name><surname>Papavasiliou</surname><given-names>F.N.</given-names></name></person-group><year>2008</year><article-title>MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase</article-title>.<source>Immunity.</source><volume>28</volume>:<fpage>621</fpage>&#x02013;<lpage>629</lpage><pub-id pub-id-type="pmid">18450484</pub-id></mixed-citation></ref><ref id="bib32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honjo</surname><given-names>T.</given-names></name><name><surname>Kinoshita</surname><given-names>K.</given-names></name><name><surname>Muramatsu</surname><given-names>M.</given-names></name></person-group><year>2002</year><article-title>Molecular mechanism of class switch recombination: linkage with somatic hypermutation</article-title>.<source>Annu. Rev. Immunol.</source><volume>20</volume>:<fpage>165</fpage>&#x02013;<lpage>196</lpage><pub-id pub-id-type="pmid">11861601</pub-id></mixed-citation></ref><ref id="bib33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bird</surname><given-names>A.W.</given-names></name><name><surname>Yu</surname><given-names>D.Y.</given-names></name><name><surname>Pray-Grant</surname><given-names>M.G.</given-names></name><name><surname>Qiu</surname><given-names>Q.</given-names></name><name><surname>Harmon</surname><given-names>K.E.</given-names></name><name><surname>Megee</surname><given-names>P.C.</given-names></name><name><surname>Grant</surname><given-names>P.A.</given-names></name><name><surname>Smith</surname><given-names>M.M.</given-names></name><name><surname>Christman</surname><given-names>M.F.</given-names></name></person-group><year>2002</year><article-title>Acetylation of histone H4 by Esa1 is required for DNA double-strand break repair</article-title>.<source>Nature.</source><volume>419</volume>:<fpage>411</fpage>&#x02013;<lpage>415</lpage><pub-id pub-id-type="pmid">12353039</pub-id></mixed-citation></ref><ref id="bib34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikura</surname><given-names>T.</given-names></name><name><surname>Ogryzko</surname><given-names>V.V.</given-names></name><name><surname>Grigoriev</surname><given-names>M.</given-names></name><name><surname>Groisman</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Horikoshi</surname><given-names>M.</given-names></name><name><surname>Scully</surname><given-names>R.</given-names></name><name><surname>Qin</surname><given-names>J.</given-names></name><name><surname>Nakatani</surname><given-names>Y.</given-names></name></person-group><year>2000</year><article-title>Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis</article-title>.<source>Cell.</source><volume>102</volume>:<fpage>463</fpage>&#x02013;<lpage>473</lpage><pub-id pub-id-type="pmid">10966108</pub-id></mixed-citation></ref><ref id="bib35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keys</surname><given-names>J.R.</given-names></name><name><surname>Tallack</surname><given-names>M.R.</given-names></name><name><surname>Zhan</surname><given-names>Y.</given-names></name><name><surname>Papathanasiou</surname><given-names>P.</given-names></name><name><surname>Goodnow</surname><given-names>C.C.</given-names></name><name><surname>Gaensler</surname><given-names>K.M.</given-names></name><name><surname>Crossley</surname><given-names>M.</given-names></name><name><surname>Dekker</surname><given-names>J.</given-names></name><name><surname>Perkins</surname><given-names>A.C.</given-names></name></person-group><year>2008</year><article-title>A mechanism for Ikaros regulation of human globin gene switching</article-title>.<source>Br. J. Haematol.</source><volume>141</volume>:<fpage>398</fpage>&#x02013;<lpage>406</lpage><pub-id pub-id-type="pmid">18318763</pub-id></mixed-citation></ref><ref id="bib36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dekker</surname><given-names>J.</given-names></name></person-group><year>2006</year><article-title>The three &#x02018;C&#x02019; s of chromosome conformation capture: controls, controls, controls</article-title>.<source>Nat. Methods.</source><volume>3</volume>:<fpage>17</fpage>&#x02013;<lpage>21</lpage><pub-id pub-id-type="pmid">16369547</pub-id></mixed-citation></ref><ref id="bib37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrozza</surname><given-names>M.J.</given-names></name><name><surname>Utley</surname><given-names>R.T.</given-names></name><name><surname>Workman</surname><given-names>J.L.</given-names></name><name><surname>Cote</surname><given-names>J.</given-names></name></person-group><year>2003</year><article-title>The diverse functions of histone acetyltransferase complexes</article-title>.<source>Trends Genet.</source><volume>19</volume>:<fpage>321</fpage>&#x02013;<lpage>329</lpage><pub-id pub-id-type="pmid">12801725</pub-id></mixed-citation></ref><ref id="bib38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinemeyer</surname><given-names>T.</given-names></name><name><surname>Wingender</surname><given-names>E.</given-names></name><name><surname>Reuter</surname><given-names>I.</given-names></name><name><surname>Hermjakob</surname><given-names>H.</given-names></name><name><surname>Kel</surname><given-names>A.E.</given-names></name><name><surname>Kel</surname><given-names>O.V.</given-names></name><name><surname>Ignatieva</surname><given-names>E.V.</given-names></name><name><surname>Ananko</surname><given-names>E.A.</given-names></name><name><surname>Podkolodnaya</surname><given-names>O.A.</given-names></name><name><surname>Kolpakov</surname><given-names>F.A.</given-names></name><etal/></person-group><year>1998</year><article-title>Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL</article-title>.<source>Nucleic Acids Res.</source><volume>26</volume>:<fpage>362</fpage>&#x02013;<lpage>367</lpage><pub-id pub-id-type="pmid">9399875</pub-id></mixed-citation></ref><ref id="bib39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strom</surname><given-names>L.</given-names></name><name><surname>Lundgren</surname><given-names>M.</given-names></name><name><surname>Severinson</surname><given-names>E.</given-names></name></person-group><year>2003</year><article-title>Binding of Ikaros to germline Ig heavy chain gamma 1 and epsilon promoters</article-title>.<source>Mol. Immunol.</source><volume>39</volume>:<fpage>771</fpage>&#x02013;<lpage>782</lpage><pub-id pub-id-type="pmid">12617992</pub-id></mixed-citation></ref><ref id="bib40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynaud</surname><given-names>S.</given-names></name><name><surname>Delpy</surname><given-names>L.</given-names></name><name><surname>Fleury</surname><given-names>L.</given-names></name><name><surname>Dougier</surname><given-names>H.L.</given-names></name><name><surname>Sirac</surname><given-names>C.</given-names></name><name><surname>Cogne</surname><given-names>M.</given-names></name></person-group><year>2005</year><article-title>Interallelic class switch recombination contributes significantly to class switching in mouse B cells</article-title>.<source>J. Immunol.</source><volume>174</volume>:<fpage>6176</fpage>&#x02013;<lpage>6183</lpage><pub-id pub-id-type="pmid">15879114</pub-id></mixed-citation></ref><ref id="bib41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dougier</surname><given-names>H.L.</given-names></name><name><surname>Reynaud</surname><given-names>S.</given-names></name><name><surname>Pinaud</surname><given-names>E.</given-names></name><name><surname>Carrion</surname><given-names>C.</given-names></name><name><surname>Delpy</surname><given-names>L.</given-names></name><name><surname>Cogne</surname><given-names>M.</given-names></name></person-group><year>2006</year><article-title>Interallelic class switch recombination can reverse allelic exclusion and allow trans-complementation of an IgH locus switching defect</article-title>.<source>Eur. J. Immunol.</source><volume>36</volume>:<fpage>2181</fpage>&#x02013;<lpage>2191</lpage><pub-id pub-id-type="pmid">16874738</pub-id></mixed-citation></ref><ref id="bib42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fear</surname><given-names>D.J.</given-names></name><name><surname>McCloskey</surname><given-names>N.</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>B.</given-names></name><name><surname>Felsenfeld</surname><given-names>G.</given-names></name><name><surname>Gould</surname><given-names>H.J.</given-names></name></person-group><year>2004</year><article-title>Transcription of Ig germline genes in single human B cells and the role of cytokines in isotype determination</article-title>.<source>J. Immunol.</source><volume>173</volume>:<fpage>4529</fpage>&#x02013;<lpage>4538</lpage><pub-id pub-id-type="pmid">15383585</pub-id></mixed-citation></ref><ref id="bib43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Carey</surname><given-names>M.</given-names></name><name><surname>Workman</surname><given-names>J.L.</given-names></name></person-group><year>2007</year><article-title>The role of chromatin during transcription</article-title>.<source>Cell.</source><volume>128</volume>:<fpage>707</fpage>&#x02013;<lpage>719</lpage><pub-id pub-id-type="pmid">17320508</pub-id></mixed-citation></ref><ref id="bib44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bulger</surname><given-names>M.</given-names></name></person-group><year>2005</year><article-title>Hyperacetylated chromatin domains: lessons from heterochromatin</article-title>.<source>J. Biol. Chem.</source><volume>280</volume>:<fpage>21689</fpage>&#x02013;<lpage>21692</lpage><pub-id pub-id-type="pmid">15840568</pub-id></mixed-citation></ref><ref id="bib45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koipally</surname><given-names>J.</given-names></name><name><surname>Renold</surname><given-names>A.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Georgopoulos</surname><given-names>K.</given-names></name></person-group><year>1999</year><article-title>Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes</article-title>.<source>EMBO J.</source><volume>18</volume>:<fpage>3090</fpage>&#x02013;<lpage>3100</lpage><pub-id pub-id-type="pmid">10357820</pub-id></mixed-citation></ref><ref id="bib46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sridharan</surname><given-names>R.</given-names></name><name><surname>Smale</surname><given-names>S.T.</given-names></name></person-group><year>2007</year><article-title>Predominant interaction of both Ikaros and Helios with the NuRD complex in immature thymocytes</article-title>.<source>J. Biol. Chem.</source><volume>282</volume>:<fpage>30227</fpage>&#x02013;<lpage>30238</lpage><pub-id pub-id-type="pmid">17681952</pub-id></mixed-citation></ref><ref id="bib47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Sif</surname><given-names>S.</given-names></name><name><surname>Jones</surname><given-names>B.</given-names></name><name><surname>Jackson</surname><given-names>A.</given-names></name><name><surname>Koipally</surname><given-names>J.</given-names></name><name><surname>Heller</surname><given-names>E.</given-names></name><name><surname>Winandy</surname><given-names>S.</given-names></name><name><surname>Viel</surname><given-names>A.</given-names></name><name><surname>Sawyer</surname><given-names>A.</given-names></name><name><surname>Ikeda</surname><given-names>T.</given-names></name><etal/></person-group><year>1999</year><article-title>Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes</article-title>.<source>Immunity.</source><volume>10</volume>:<fpage>345</fpage>&#x02013;<lpage>355</lpage><pub-id pub-id-type="pmid">10204490</pub-id></mixed-citation></ref><ref id="bib48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koipally</surname><given-names>J.</given-names></name><name><surname>Georgopoulos</surname><given-names>K.</given-names></name></person-group><year>2002</year><article-title>A molecular dissection of the repression circuitry of Ikaros</article-title>.<source>J. Biol. Chem.</source><volume>277</volume>:<fpage>27697</fpage>&#x02013;<lpage>27705</lpage><pub-id pub-id-type="pmid">12015313</pub-id></mixed-citation></ref><ref id="bib49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>D.I.</given-names></name><name><surname>Fiering</surname><given-names>S.</given-names></name><name><surname>Groudine</surname><given-names>M.</given-names></name></person-group><year>1996</year><article-title>Regulation of beta-globin gene expression: straightening out the locus</article-title>.<source>Curr. Opin. Genet. Dev.</source><volume>6</volume>:<fpage>488</fpage>&#x02013;<lpage>495</lpage><pub-id pub-id-type="pmid">8791532</pub-id></mixed-citation></ref><ref id="bib50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Birshtein</surname><given-names>B.K.</given-names></name></person-group><year>1997</year><article-title>Virtually identical enhancers containing a segment of homology to murine 3&#x02032;IgH-E(hs1,2) lie downstream of human Ig C alpha 1 and C alpha 2 genes</article-title>.<source>J. Immunol.</source><volume>159</volume>:<fpage>1310</fpage>&#x02013;<lpage>1318</lpage><pub-id pub-id-type="pmid">9233627</pub-id></mixed-citation></ref><ref id="bib51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chauveau</surname><given-names>C.</given-names></name><name><surname>Pinaud</surname><given-names>E.</given-names></name><name><surname>Cogne</surname><given-names>M.</given-names></name></person-group><year>1998</year><article-title>Synergies between regulatory elements of the immunoglobulin heavy chain locus and its palindromic 3&#x02032; locus control region</article-title>.<source>Eur. J. Immunol.</source><volume>28</volume>:<fpage>3048</fpage>&#x02013;<lpage>3056</lpage><pub-id pub-id-type="pmid">9808173</pub-id></mixed-citation></ref><ref id="bib52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>F.C.</given-names></name><name><surname>Harindranath</surname><given-names>N.</given-names></name><name><surname>Mitchell</surname><given-names>M.</given-names></name><name><surname>Max</surname><given-names>E.E.</given-names></name></person-group><year>1997</year><article-title>Enhancer complexes located downstream of both human immunoglobulin C&#x003b1; genes</article-title>.<source>J. Exp. Med.</source><volume>186</volume>:<fpage>845</fpage>&#x02013;<lpage>858</lpage><pub-id pub-id-type="pmid">9294139</pub-id></mixed-citation></ref><ref id="bib53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trinh</surname><given-names>L.A.</given-names></name><name><surname>Ferrini</surname><given-names>R.</given-names></name><name><surname>Cobb</surname><given-names>B.S.</given-names></name><name><surname>Weinmann</surname><given-names>A.S.</given-names></name><name><surname>Hahm</surname><given-names>K.</given-names></name><name><surname>Ernst</surname><given-names>P.</given-names></name><name><surname>Garraway</surname><given-names>I.P.</given-names></name><name><surname>Merkenschlager</surname><given-names>M.</given-names></name><name><surname>Smale</surname><given-names>S.T.</given-names></name></person-group><year>2001</year><article-title>Down-regulation of TDT transcription in CD4(+)CD8(+) thymocytes by Ikaros proteins in direct competition with an Ets activator</article-title>.<source>Genes Dev.</source><volume>15</volume>:<fpage>1817</fpage>&#x02013;<lpage>1832</lpage><pub-id pub-id-type="pmid">11459831</pub-id></mixed-citation></ref><ref id="bib54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleinmann</surname><given-names>E.</given-names></name><name><surname>Geimer Le Lay</surname><given-names>A.S.</given-names></name><name><surname>Sellars</surname><given-names>M.</given-names></name><name><surname>Kastner</surname><given-names>P.</given-names></name><name><surname>Chan</surname><given-names>S.</given-names></name></person-group><year>2008</year><article-title>Ikaros represses the transcriptional response to Notch signaling in T-cell development</article-title>.<source>Mol. Cell. Biol.</source><volume>28</volume>:<fpage>7465</fpage>&#x02013;<lpage>7475</lpage><comment>(PubMed)</comment><pub-id pub-id-type="pmid">18852286</pub-id></mixed-citation></ref><ref id="bib55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>C.</given-names></name><name><surname>Mills</surname><given-names>K.D.</given-names></name><name><surname>Ferguson</surname><given-names>D.O.</given-names></name><name><surname>Lee</surname><given-names>C.</given-names></name><name><surname>Manis</surname><given-names>J.</given-names></name><name><surname>Fleming</surname><given-names>J.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Morton</surname><given-names>C.C.</given-names></name><name><surname>Alt</surname><given-names>F.W.</given-names></name></person-group><year>2002</year><article-title>Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations</article-title>.<source>Cell.</source><volume>109</volume>:<fpage>811</fpage>&#x02013;<lpage>821</lpage><pub-id pub-id-type="pmid">12110179</pub-id></mixed-citation></ref><ref id="bib56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Izon</surname><given-names>D.J.</given-names></name><name><surname>Punt</surname><given-names>J.A.</given-names></name><name><surname>Xu</surname><given-names>L.</given-names></name><name><surname>Karnell</surname><given-names>F.G.</given-names></name><name><surname>Allman</surname><given-names>D.</given-names></name><name><surname>Myung</surname><given-names>P.S.</given-names></name><name><surname>Boerth</surname><given-names>N.J.</given-names></name><name><surname>Pui</surname><given-names>J.C.</given-names></name><name><surname>Koretzky</surname><given-names>G.A.</given-names></name><name><surname>Pear</surname><given-names>W.S.</given-names></name></person-group><year>2001</year><article-title>Notch1 regulates maturation of CD4+ and CD8+ thymocytes by modulating TCR signal strength</article-title>.<source>Immunity.</source><volume>14</volume>:<fpage>253</fpage>&#x02013;<lpage>264</lpage><pub-id pub-id-type="pmid">11290335</pub-id></mixed-citation></ref><ref id="bib57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramirez-Carrozzi</surname><given-names>V.R.</given-names></name><name><surname>Nazarian</surname><given-names>A.A.</given-names></name><name><surname>Li</surname><given-names>C.C.</given-names></name><name><surname>Gore</surname><given-names>S.L.</given-names></name><name><surname>Sridharan</surname><given-names>R.</given-names></name><name><surname>Imbalzano</surname><given-names>A.N.</given-names></name><name><surname>Smale</surname><given-names>S.T.</given-names></name></person-group><year>2006</year><article-title>Selective and antagonistic functions of SWI/SNF and Mi-2beta nucleosome remodeling complexes during an inflammatory response</article-title>.<source>Genes Dev.</source><volume>20</volume>:<fpage>282</fpage>&#x02013;<lpage>296</lpage><pub-id pub-id-type="pmid">16452502</pub-id></mixed-citation></ref><ref id="bib58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nowak</surname><given-names>D.E.</given-names></name><name><surname>Tian</surname><given-names>B.</given-names></name><name><surname>Brasier</surname><given-names>A.R.</given-names></name></person-group><year>2005</year><article-title>Two-step cross-linking method for identification of NF-kappaB gene network by chromatin immunoprecipitation</article-title>.<source>Biotechniques.</source><volume>39</volume>:<fpage>715</fpage>&#x02013;<lpage>725</lpage><pub-id pub-id-type="pmid">16315372</pub-id></mixed-citation></ref><ref id="bib59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tolhuis</surname><given-names>B.</given-names></name><name><surname>Palstra</surname><given-names>R.J.</given-names></name><name><surname>Splinter</surname><given-names>E.</given-names></name><name><surname>Grosveld</surname><given-names>F.</given-names></name><name><surname>de Laat</surname><given-names>W.</given-names></name></person-group><year>2002</year><article-title>Looping and interaction between hypersensitive sites in the active beta-globin locus</article-title>.<source>Mol. Cell.</source><volume>10</volume>:<fpage>1453</fpage>&#x02013;<lpage>1465</lpage><pub-id pub-id-type="pmid">12504019</pub-id></mixed-citation></ref><ref id="bib60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dostie</surname><given-names>J.</given-names></name><name><surname>Dekker</surname><given-names>J.</given-names></name></person-group><year>2007</year><article-title>Mapping networks of physical interactions between genomic elements using 5C technology</article-title>.<source>Nat. Protoc.</source><volume>2</volume>:<fpage>988</fpage>&#x02013;<lpage>1002</lpage><pub-id pub-id-type="pmid">17446898</pub-id></mixed-citation></ref><ref id="bib61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dumortier</surname><given-names>A.</given-names></name><name><surname>Jeannet</surname><given-names>R.</given-names></name><name><surname>Kirstetter</surname><given-names>P.</given-names></name><name><surname>Kleinmann</surname><given-names>E.</given-names></name><name><surname>Sellars</surname><given-names>M.</given-names></name><name><surname>dos Santos</surname><given-names>N.R.</given-names></name><name><surname>Thibault</surname><given-names>C.</given-names></name><name><surname>Barths</surname><given-names>J.</given-names></name><name><surname>Ghysdael</surname><given-names>J.</given-names></name><name><surname>Punt</surname><given-names>J.A.</given-names></name><etal/></person-group><year>2006</year><article-title>Notch activation is an early and critical event during T-cell leukemogenesis in Ikaros-deficient mice</article-title>.<source>Mol. Cell. Biol.</source><volume>26</volume>:<fpage>209</fpage>&#x02013;<lpage>220</lpage><pub-id pub-id-type="pmid">16354692</pub-id></mixed-citation></ref></ref-list><fn-group><fn><p>Abbreviations used: 3C, chromosome conformation capture; AcH3, histone H3 acetylation; AID, activation-induced cytidine deaminase; ChIP, chromatin immunoprecipitation; CSR, class switch recombination; DSB, double-stranded DNA break; GLT, germline transcript; HDAC, histone deacetylase; HS, hypersensitive; I, intronic; NGFR, nerve growth factor receptor; qPCR, quantitative PCR; S, switch; SC, single cell.</p></fn></fn-group></back></article>